ID   14KL_BRUO2              Reviewed;         147 AA.
AC   A5VV34;
DT   20-JAN-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 1.
DT   11-NOV-2015, entry version 51.
DE   RecName: Full=Lectin-like protein BA14k;
DE   Flags: Precursor;
GN   OrderedLocusNames=BOV_A0688;
OS   Brucella ovis (strain ATCC 25840 / 63/290 / NCTC 10512).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales;
OC   Brucellaceae; Brucella.
OX   NCBI_TaxID=444178;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25840 / 63/290 / NCTC 10512;
RX   PubMed=19436743; DOI=10.1371/journal.pone.0005519;
RA   Tsolis R.M., Seshadri R., Santos R.L., Sangari F.J., Lobo J.M.,
RA   de Jong M.F., Ren Q., Myers G., Brinkac L.M., Nelson W.C., Deboy R.T.,
RA   Angiuoli S., Khouri H., Dimitrov G., Robinson J.R., Mulligan S.,
RA   Walker R.L., Elzer P.E., Hassan K.A., Paulsen I.T.;
RT   "Genome degradation in Brucella ovis corresponds with narrowing of its
RT   host range and tissue tropism.";
RL   PLoS ONE 4:E5519-E5519(2009).
CC   -!- FUNCTION: Has immunoglobulin-binding and hemagglutination
CC       properties, and can bind to mannose. Essential for virulence. May
CC       be involved in LPS biosynthesis or polysaccharide transport (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the BA14k family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000709; ABQ62335.1; -; Genomic_DNA.
DR   RefSeq; WP_002965908.1; NC_009504.1.
DR   PRIDE; A5VV34; -.
DR   EnsemblBacteria; ABQ62335; ABQ62335; BOV_A0688.
DR   GeneID; 3827602; -.
DR   KEGG; bov:BOV_A0688; -.
DR   PATRIC; 17858701; VBIBruOvi136990_0790.
DR   HOGENOM; HOG000274446; -.
DR   OMA; HVAWCAN; -.
DR   OrthoDB; EOG6358FW; -.
DR   BioCyc; BOVI444178:GH2V-2782-MONOMER; -.
DR   Proteomes; UP000006383; Chromosome II.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   InterPro; IPR012413; BA14K.
DR   Pfam; PF07886; BA14K; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Complete proteome; Lectin; Membrane; Signal;
KW   Transmembrane; Transmembrane helix; Virulence.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    147       Lectin-like protein BA14k.
FT                                /FTId=PRO_0000361300.
FT   TRANSMEM     80    100       Helical. {ECO:0000255}.
SQ   SEQUENCE   147 AA;  16823 MW;  7CEE6F1FB2BB38DB CRC64;
     MNSFRKTCAG ALALIFGATS IVPTVAAPMN MDRPAINQNV IQARAHYRPQ NYNRGHRPGY
     WHGHRGYRHY RHGYRRHNDG WWYPLAAFGA GAIIGGAISQ PRPVYRAPAG SPHVQWCYSR
     YKSYRASDNT FQPYNGPRKQ CRSPYSR
//
ID   14KL_OCHA4              Reviewed;         151 AA.
AC   A6X5T5;
DT   20-JAN-2009, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 1.
DT   11-NOV-2015, entry version 51.
DE   RecName: Full=Lectin-like protein BA14k;
DE   Flags: Precursor;
GN   OrderedLocusNames=Oant_3884;
OS   Ochrobactrum anthropi (strain ATCC 49188 / DSM 6882 / NCTC 12168).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales;
OC   Brucellaceae; Ochrobactrum.
OX   NCBI_TaxID=439375;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 49188 / DSM 6882 / NCTC 12168;
RX   PubMed=21685287; DOI=10.1128/JB.05335-11;
RA   Chain P.S., Lang D.M., Comerci D.J., Malfatti S.A., Vergez L.M.,
RA   Shin M., Ugalde R.A., Garcia E., Tolmasky M.E.;
RT   "Genome of Ochrobactrum anthropi ATCC 49188 T, a versatile
RT   opportunistic pathogen and symbiont of several eukaryotic hosts.";
RL   J. Bacteriol. 193:4274-4275(2011).
CC   -!- FUNCTION: Has immunoglobulin-binding and hemagglutination
CC       properties, and can bind to mannose. Essential for virulence. May
CC       be involved in LPS biosynthesis or polysaccharide transport (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the BA14k family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP000759; ABS16589.1; -; Genomic_DNA.
DR   RefSeq; WP_012093240.1; NC_009668.1.
DR   STRING; 439375.Oant_3884; -.
DR   EnsemblBacteria; ABS16589; ABS16589; Oant_3884.
DR   GeneID; 5381536; -.
DR   KEGG; oan:Oant_3884; -.
DR   PATRIC; 20473170; VBIOchAnt73124_4053.
DR   eggNOG; ENOG4105W6J; Bacteria.
DR   eggNOG; ENOG41122WP; LUCA.
DR   HOGENOM; HOG000274446; -.
DR   OMA; GPRRICV; -.
DR   OrthoDB; EOG6358FW; -.
DR   BioCyc; OANT439375:GJIT-3948-MONOMER; -.
DR   BioCyc; RETL1328306-WGS:GSTH-917-MONOMER; -.
DR   Proteomes; UP000002301; Chromosome 2.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   InterPro; IPR012413; BA14K.
DR   Pfam; PF07886; BA14K; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Complete proteome; Lectin; Membrane;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Virulence.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    151       Lectin-like protein BA14k.
FT                                /FTId=PRO_5000262091.
FT   TRANSMEM     83    103       Helical. {ECO:0000255}.
SQ   SEQUENCE   151 AA;  17666 MW;  D50A0ADC9DD99128 CRC64;
     MNIFKQTCVG AFAVIFGATS IAPTMAAPLN LERPVINHNV EQVRDHRRPP RHYNGHRPHR
     PGYWNGHRGY RHYRHGYRRY NDGWWYPLAA FGAGAIIGGA VSQPRPVYRA PRMSNAHVQW
     CYNRYKSYRS SDNTFQPYNG PRRQCYSPYS R
//
ID   16D10_MELJA             Reviewed;          43 AA.
AC   Q06JG6;
DT   30-NOV-2010, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2006, sequence version 1.
DT   07-JAN-2015, entry version 10.
DE   RecName: Full=CLAVATA3/ESR (CLE)-related protein 16D10;
DE   Flags: Precursor;
GN   Name=16D10;
OS   Meloidogyne javanica (Root-knot nematode worm).
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Tylenchida;
OC   Tylenchina; Tylenchoidea; Meloidogynidae; Meloidogyninae; Meloidogyne;
OC   Meloidogyne incognita group.
OX   NCBI_TaxID=6303;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=16985000; DOI=10.1073/pnas.0604698103;
RA   Huang G., Allen R., Davis E.L., Baum T.J., Hussey R.S.;
RT   "Engineering broad root-knot resistance in transgenic plants by RNAi
RT   silencing of a conserved and essential root-knot nematode parasitism
RT   gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14302-14306(2006).
RN   [2]
RP   REVIEW.
RX   PubMed=18078779; DOI=10.1016/j.pbi.2007.10.010;
RA   Mitchum M.G., Wang X., Davis E.L.;
RT   "Diverse and conserved roles of CLE peptides.";
RL   Curr. Opin. Plant Biol. 11:75-81(2008).
CC   -!- FUNCTION: Plays a role in the differentiation or division of
CC       feeding cells (syncytia) induced in plant roots during infection.
CC       Promotes host root growth. {ECO:0000269|PubMed:16985000}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Host cytoplasm
CC       {ECO:0000250}. Host extracellular space {ECO:0000250}.
CC       Note=Secreted into host root cells via the nematode stylet to
CC       transform the recipient cells into enlarged multinucleate feeding
CC       cells called giant-cells or syncytia. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed exclusively within the
CC       subventral esophageal gland cell during syncytium formation in
CC       host plants.
CC   -!- SIMILARITY: Belongs to the CLV3/ESR signal peptide family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ841121; ABI33931.1; -; Genomic_DNA.
DR   GO; GO:0043655; C:extracellular space of host; IEA:UniProtKB-SubCell.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
PE   2: Evidence at transcript level;
KW   Differentiation; Host cytoplasm; Secreted; Signal.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31     43       CLAVATA3/ESR (CLE)-related protein 16D10.
FT                                /FTId=PRO_0000401217.
FT   MOTIF        31     43       CLE.
SQ   SEQUENCE   43 AA;  4625 MW;  CC5E0C37E220AF2E CRC64;
     MFTNSIKNLI IYLMPLMVTL MLLSVSFVDA GKKPSGPNPG GNN
//
ID   17KD_RICBE              Reviewed;         159 AA.
AC   Q84I68;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   11-NOV-2015, entry version 37.
DE   RecName: Full=17 kDa surface antigen;
DE   Flags: Precursor;
GN   Name=omp;
OS   Rickettsia bellii.
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rickettsiales;
OC   Rickettsiaceae; Rickettsieae; Rickettsia; belli group.
OX   NCBI_TaxID=33990;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=G2D42;
RA   Stothard D.R., Pretzman C.I., Fuerst P.A., Feng H.-M., Walker D.H.,
RA   Bouyer D.H.;
RT   "Classification of Rickettsia amblyommii sp. nov. isolated from the
RT   Lone Star Tick, Amblyomma americanum (Acari: Ixodidae), based upon 17,
RT   120 and 130 kilodalton antigen gene phylogenies.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Cell outer membrane {ECO:0000305}; Lipid-
CC       anchor {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the rickettsiale 17 kDa surface antigen
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF445380; AAO38433.1; -; Genomic_DNA.
DR   STRING; 391896.A1I_07925; -.
DR   eggNOG; ENOG4105MQ2; Bacteria.
DR   eggNOG; COG4520; LUCA.
DR   GO; GO:0009279; C:cell outer membrane; IEA:UniProtKB-SubCell.
DR   InterPro; IPR032635; Anti_2.
DR   InterPro; IPR008816; Gly_zipper_2TM_dom.
DR   InterPro; IPR016364; Surface_antigen_Rickettsia.
DR   Pfam; PF16998; 17kDa_Anti_2; 1.
DR   Pfam; PF05433; Rick_17kDa_Anti; 1.
DR   PIRSF; PIRSF002721; Surface_antigen_Rickettsia; 1.
DR   PROSITE; PS51257; PROKAR_LIPOPROTEIN; 1.
PE   3: Inferred from homology;
KW   Cell outer membrane; Lipoprotein; Membrane; Palmitate; Signal.
FT   SIGNAL        1     19       {ECO:0000255|PROSITE-ProRule:PRU00303}.
FT   CHAIN        20    159       17 kDa surface antigen.
FT                                /FTId=PRO_0000277890.
FT   LIPID        20     20       N-palmitoyl cysteine. {ECO:0000305}.
FT   LIPID        20     20       S-diacylglycerol cysteine. {ECO:0000305}.
SQ   SEQUENCE   159 AA;  16331 MW;  86BB5171CF09DBE7 CRC64;
     MKIISKIIVI LLAASMLQAC QGPGGMNKQG SGTLIGGTAG ALLGSQFGGG TGRLAAVGAG
     ALLGAILGNQ IGAGMDEQDR KLAELTSQRA LEAAPSGSSV QWRNPDNGNY GTVTPSKAYK
     NNTGQYCREY TQTVVVGGKQ QKAYGTACRQ PDGQWQVVN
//
ID   17KD_RICFE              Reviewed;         159 AA.
AC   Q9F9F2; Q4UJW7;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   11-NOV-2015, entry version 63.
DE   RecName: Full=17 kDa surface antigen;
DE   Flags: Precursor;
GN   Name=omp; OrderedLocusNames=RF_1321;
OS   Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rickettsiales;
OC   Rickettsiaceae; Rickettsieae; Rickettsia; spotted fever group.
OX   NCBI_TaxID=315456;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11321078;
RA   Bouyer D.H., Stenos J., Crocquet-Valdes P., Moron C.G., Popov V.L.,
RA   Zavala-Velazquez J.E., Foil L.D., Stothard D.R., Azad A.F.,
RA   Walker D.H.;
RT   "Rickettsia felis: molecular characterization of a new member of the
RT   spotted fever group.";
RL   Int. J. Syst. Evol. Microbiol. 51:339-347(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC VR-1525 / URRWXCal2;
RX   PubMed=15984913; DOI=10.1371/journal.pbio.0030248;
RA   Ogata H., Renesto P., Audic S., Robert C., Blanc G., Fournier P.-E.,
RA   Parinello H., Claverie J.-M., Raoult D.;
RT   "The genome sequence of Rickettsia felis identifies the first putative
RT   conjugative plasmid in an obligate intracellular parasite.";
RL   PLoS Biol. 3:1-12(2005).
CC   -!- SUBCELLULAR LOCATION: Cell outer membrane {ECO:0000305}; Lipid-
CC       anchor {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the rickettsiale 17 kDa surface antigen
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF195118; AAG28452.1; -; Genomic_DNA.
DR   EMBL; CP000053; AAY62172.1; -; Genomic_DNA.
DR   RefSeq; WP_011271621.1; NC_007109.1.
DR   STRING; 315456.RF_1321; -.
DR   EnsemblBacteria; AAY62172; AAY62172; RF_1321.
DR   KEGG; rfe:RF_1321; -.
DR   PATRIC; 17893562; VBIRicFel64634_1592.
DR   eggNOG; ENOG4105MQ2; Bacteria.
DR   eggNOG; COG4520; LUCA.
DR   HOGENOM; HOG000285721; -.
DR   OMA; IGETITW; -.
DR   OrthoDB; EOG65N1H5; -.
DR   BioCyc; RFEL315456:GKEK-1357-MONOMER; -.
DR   Proteomes; UP000008548; Chromosome.
DR   GO; GO:0009279; C:cell outer membrane; IEA:UniProtKB-SubCell.
DR   InterPro; IPR032635; Anti_2.
DR   InterPro; IPR008816; Gly_zipper_2TM_dom.
DR   InterPro; IPR016364; Surface_antigen_Rickettsia.
DR   Pfam; PF16998; 17kDa_Anti_2; 1.
DR   Pfam; PF05433; Rick_17kDa_Anti; 1.
DR   PIRSF; PIRSF002721; Surface_antigen_Rickettsia; 1.
DR   PROSITE; PS51257; PROKAR_LIPOPROTEIN; 1.
PE   3: Inferred from homology;
KW   Cell outer membrane; Complete proteome; Lipoprotein; Membrane;
KW   Palmitate; Signal.
FT   SIGNAL        1     19       {ECO:0000255|PROSITE-ProRule:PRU00303}.
FT   CHAIN        20    159       17 kDa surface antigen.
FT                                /FTId=PRO_0000277889.
FT   LIPID        20     20       N-palmitoyl cysteine. {ECO:0000305}.
FT   LIPID        20     20       S-diacylglycerol cysteine. {ECO:0000305}.
SQ   SEQUENCE   159 AA;  16497 MW;  34C5B020AF470A1F CRC64;
     MKLLSKIMII ALAASMLQAC NGPGGMNKQG TGTLLGGAGG ALLGSQFGKG KGQLVGVGVG
     ALLGAVLGGQ IGAGMDEQDR RLAELTSQRA LEATPSGTSV EWRNPDNGNH GYVTPNKTYR
     NSTGQYCREY TQTVVIGGKQ QKAYGNACRQ PDGLWQVVN
//
ID   17KD_RICTY              Reviewed;         159 AA.
AC   P22882; Q68Y14;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   09-NOV-2004, sequence version 2.
DT   11-NOV-2015, entry version 83.
DE   RecName: Full=17 kDa surface antigen;
DE   Flags: Precursor;
GN   Name=omp; OrderedLocusNames=RT0821;
OS   Rickettsia typhi (strain ATCC VR-144 / Wilmington).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rickettsiales;
OC   Rickettsiaceae; Rickettsieae; Rickettsia; typhus group.
OX   NCBI_TaxID=257363;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2768201;
RA   Anderson B.E., Tzianabos T.;
RT   "Comparative sequence analysis of a genus-common rickettsial antigen
RT   gene.";
RL   J. Bacteriol. 171:5199-5201(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC VR-144 / Wilmington;
RX   PubMed=15317790; DOI=10.1128/JB.186.17.5842-5855.2004;
RA   McLeod M.P., Qin X., Karpathy S.E., Gioia J., Highlander S.K.,
RA   Fox G.E., McNeill T.Z., Jiang H., Muzny D., Jacob L.S., Hawes A.C.,
RA   Sodergren E., Gill R., Hume J., Morgan M., Fan G., Amin A.G.,
RA   Gibbs R.A., Hong C., Yu X.-J., Walker D.H., Weinstock G.M.;
RT   "Complete genome sequence of Rickettsia typhi and comparison with
RT   sequences of other Rickettsiae.";
RL   J. Bacteriol. 186:5842-5855(2004).
CC   -!- SUBCELLULAR LOCATION: Cell outer membrane {ECO:0000305}; Lipid-
CC       anchor {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the rickettsiale 17 kDa surface antigen
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28481; AAA26377.1; -; Genomic_DNA.
DR   EMBL; AE017197; AAU04276.1; -; Genomic_DNA.
DR   PIR; C33971; C33971.
DR   RefSeq; WP_011191250.1; NC_006142.1.
DR   STRING; 257363.RT0821; -.
DR   EnsemblBacteria; AAU04276; AAU04276; RT0821.
DR   KEGG; rty:RT0821; -.
DR   PATRIC; 17910892; VBIRicTyp34752_0838.
DR   eggNOG; ENOG4105MQ2; Bacteria.
DR   eggNOG; COG4520; LUCA.
DR   HOGENOM; HOG000285721; -.
DR   OMA; IGETITW; -.
DR   OrthoDB; EOG65N1H5; -.
DR   BioCyc; RTYP257363:GJEQ-861-MONOMER; -.
DR   Proteomes; UP000000604; Chromosome.
DR   GO; GO:0009279; C:cell outer membrane; IEA:UniProtKB-SubCell.
DR   InterPro; IPR032635; Anti_2.
DR   InterPro; IPR008816; Gly_zipper_2TM_dom.
DR   InterPro; IPR016364; Surface_antigen_Rickettsia.
DR   Pfam; PF16998; 17kDa_Anti_2; 1.
DR   Pfam; PF05433; Rick_17kDa_Anti; 1.
DR   PIRSF; PIRSF002721; Surface_antigen_Rickettsia; 1.
DR   PROSITE; PS51257; PROKAR_LIPOPROTEIN; 1.
PE   3: Inferred from homology;
KW   Cell outer membrane; Complete proteome; Lipoprotein; Membrane;
KW   Palmitate; Signal.
FT   SIGNAL        1     19       {ECO:0000255|PROSITE-ProRule:PRU00303}.
FT   CHAIN        20    159       17 kDa surface antigen.
FT                                /FTId=PRO_0000018023.
FT   LIPID        20     20       N-palmitoyl cysteine. {ECO:0000305}.
FT   LIPID        20     20       S-diacylglycerol cysteine. {ECO:0000305}.
FT   CONFLICT     75     75       M -> L (in Ref. 1; AAA26377).
FT                                {ECO:0000305}.
FT   CONFLICT    158    158       A -> V (in Ref. 1; AAA26377).
FT                                {ECO:0000305}.
SQ   SEQUENCE   159 AA;  16539 MW;  A9893F26492727A9 CRC64;
     MKLLSKVMIL ALAASMLQAC NGPGGMNKQG TGTLLGGAGG ALLGSQFGHG KGQLVGVGVG
     ALLGAVLGGQ IGASMDEQDR KLLELTSQRA LESAPSGSNI EWRNPDNGNH GYVTPNKTYR
     NSTGQYCREY TQTVVIGGKQ QTTYGNACRQ PDGQWQVAN
//
ID   1A02_GORGO              Reviewed;         365 AA.
AC   P30376;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   14-OCT-2015, entry version 84.
DE   RecName: Full=Class I histocompatibility antigen, Gogo-A*0201 alpha chain;
DE   Flags: Precursor;
OS   Gorilla gorilla gorilla (Western lowland gorilla).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Gorilla.
OX   NCBI_TaxID=9595;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1744581; DOI=10.1084/jem.174.6.1491;
RA   Lawlor D.A., Warren E., Taylor P., Parham P.;
RT   "Gorilla class I major histocompatibility complex alleles: comparison
RT   to human and chimpanzee class I.";
RL   J. Exp. Med. 174:1491-1509(1991).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60259; CAA42811.1; -; mRNA.
DR   PIR; JH0535; JH0535.
DR   ProteinModelPortal; P30376; -.
DR   SMR; P30376; 25-300.
DR   HOVERGEN; HBG016709; -.
DR   Proteomes; UP000001519; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; IEA:InterPro.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Immunity; Membrane;
KW   MHC I; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    365       Class I histocompatibility antigen, Gogo-
FT                                A*0201 alpha chain.
FT                                /FTId=PRO_0000018898.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
SQ   SEQUENCE   365 AA;  40896 MW;  09E0E5FCD8E58507 CRC64;
     MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEE PEYWDGETRK VKAHSQTDRV NLGTLRGYYN QSEAGSHTIQ
     KMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAEITKRK WEAAHFAEQL
     RAYLEGECVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEAILRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHESL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VIAGAVIAAV RWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A02_PANTR              Reviewed;         362 AA.
AC   P16210;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   17-FEB-2016, entry version 110.
DE   RecName: Full=Patr class I histocompatibility antigen, A-5 alpha chain;
DE   AltName: Full=ChLa class I histocompatibility antigen, A-5 alpha chain;
DE   Flags: Precursor;
OS   Pan troglodytes (Chimpanzee).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Pan.
OX   NCBI_TaxID=9598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1690682; DOI=10.1111/j.1600-065X.1990.tb00040.x;
RA   Lawlor D.A., Warren E., Ward F.E., Parham P.;
RT   "Comparison of class I MHC alleles in humans and apes.";
RL   Immunol. Rev. 113:147-185(1990).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30679; AAA87971.1; -; mRNA.
DR   PIR; I36962; I36962.
DR   UniGene; Ptr.1473; -.
DR   ProteinModelPortal; P16210; -.
DR   SMR; P16210; 25-301.
DR   STRING; 9598.ENSPTRP00000061016; -.
DR   PaxDb; P16210; -.
DR   PRIDE; P16210; -.
DR   Ensembl; ENSPTRT00000072427; ENSPTRP00000061016; ENSPTRG00000038986.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   GeneTree; ENSGT00760000118960; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P16210; -.
DR   OMA; EREDQEY; -.
DR   OrthoDB; EOG7JT6WQ; -.
DR   TreeFam; TF336617; -.
DR   Proteomes; UP000002277; Chromosome 6.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0003823; F:antigen binding; IBA:GO_Central.
DR   GO; GO:0042605; F:peptide antigen binding; IEA:InterPro.
DR   GO; GO:0019882; P:antigen processing and presentation; IBA:GO_Central.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IEA:Ensembl.
DR   GO; GO:2001198; P:regulation of dendritic cell differentiation; IEA:Ensembl.
DR   GO; GO:0032655; P:regulation of interleukin-12 production; IEA:Ensembl.
DR   GO; GO:0032675; P:regulation of interleukin-6 production; IEA:Ensembl.
DR   GO; GO:0002667; P:regulation of T cell anergy; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Immunity; Membrane;
KW   MHC I; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    362       Patr class I histocompatibility antigen,
FT                                A-5 alpha chain.
FT                                /FTId=PRO_0000018911.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
SQ   SEQUENCE   362 AA;  40487 MW;  9B5A674445037056 CRC64;
     MQVTAPRTVL LLLSAALALT ETWAGSHSMK YFYTAVSRPG RGEPRFISVG YVDDTQFVWF
     DSDAASPREE PRAPWIEQEG PEYWDRETQI SKTNAQTYRE SLRNLRGYYN QSEAGSHIIQ
     RMYGCDMGPD GRLLRGYEQY AYDGKDYIAL NQDLSSWTAA DTAAQITQRK WEAARWAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1A04_GORGO              Reviewed;         365 AA.
AC   P30378;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   14-OCT-2015, entry version 88.
DE   RecName: Full=Class I histocompatibility antigen, Gogo-A*0501 alpha chain;
DE   Flags: Precursor;
OS   Gorilla gorilla gorilla (Western lowland gorilla).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Gorilla.
OX   NCBI_TaxID=9595;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1744581; DOI=10.1084/jem.174.6.1491;
RA   Lawlor D.A., Warren E., Taylor P., Parham P.;
RT   "Gorilla class I major histocompatibility complex alleles: comparison
RT   to human and chimpanzee class I.";
RL   J. Exp. Med. 174:1491-1509(1991).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60256; CAA42808.1; -; mRNA.
DR   PIR; JH0537; JH0537.
DR   RefSeq; NP_001266480.1; NM_001279551.1.
DR   ProteinModelPortal; P30378; -.
DR   SMR; P30378; 25-302.
DR   PRIDE; P30378; -.
DR   GeneID; 101141279; -.
DR   HOVERGEN; HBG016709; -.
DR   Proteomes; UP000001519; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; IEA:InterPro.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Immunity; Membrane;
KW   MHC I; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    365       Class I histocompatibility antigen, Gogo-
FT                                A*0501 alpha chain.
FT                                /FTId=PRO_0000018900.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
SQ   SEQUENCE   365 AA;  40896 MW;  340DAD21F9B3B8AB CRC64;
     MAVVAPRTLL LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWMEQEE PEYWDRQTQI SKTNAQIELE SLRIALRYYN QSEDGSHTIQ
     RMYGCDVGSD GRFLRGYQQD AYDGKDYIAS NEDLRSWTAA DMAAEITKRK WEAAHFAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THTTHQAVSD HEATLKCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A04_PANTR              Reviewed;         365 AA.
AC   P13749; Q7JJU4;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   11-NOV-2015, entry version 98.
DE   RecName: Full=Patr class I histocompatibility antigen, A-126 alpha chain;
DE   AltName: Full=ChLa class I histocompatibility antigen, A-126 alpha chain;
DE   AltName: Full=MHC class I antigen Patr-A*0401;
DE   Flags: Precursor;
GN   Name=Patr-A;
OS   Pan troglodytes (Chimpanzee).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Pan.
OX   NCBI_TaxID=9598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2460344;
RA   Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.;
RT   "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for
RT   trans-species mode of evolution.";
RL   EMBO J. 7:2765-2774(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=10866106; DOI=10.1007/s002510050638;
RA   de Groot N.G., Otting N., Arguello R., Watkins D.I., Doxiadis G.G.,
RA   Madrigal J.A., Bontrop R.E.;
RT   "Major histocompatibility complex class I diversity in a West African
RT   chimpanzee population: implications for HIV research.";
RL   Immunogenetics 51:398-409(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12799463; DOI=10.1073/pnas.1230533100;
RA   Anzai T., Shiina T., Kimura N., Yanagiya K., Kohara S., Shigenari A.,
RA   Yamagata T., Kulski J.K., Naruse T.K., Fujimori Y., Fukuzumi Y.,
RA   Yamazaki M., Tashiro H., Iwamoto C., Umehara Y., Imanishi T.,
RA   Meyer A., Ikeo K., Gojobori T., Bahram S., Inoko H.;
RT   "Comparative sequencing of human and chimpanzee MHC class I regions
RT   unveils insertions/deletions as the major path to genomic
RT   divergence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7708-7713(2003).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13114; CAA31506.1; -; mRNA.
DR   EMBL; AF168401; AAF72782.1; -; mRNA.
DR   EMBL; BA000041; BAC78189.1; -; Genomic_DNA.
DR   PIR; S01171; S01171.
DR   UniGene; Ptr.2590; -.
DR   ProteinModelPortal; P13749; -.
DR   SMR; P13749; 25-299.
DR   STRING; 9598.ENSPTRP00000056399; -.
DR   PaxDb; P13749; -.
DR   PRIDE; P13749; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   NextBio; 20833111; -.
DR   Proteomes; UP000002277; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; IEA:InterPro.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Immunity; Membrane;
KW   MHC I; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    365       Patr class I histocompatibility antigen,
FT                                A-126 alpha chain.
FT                                /FTId=PRO_0000018913.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P10314}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
SQ   SEQUENCE   365 AA;  40656 MW;  D3C9A810B22A768F CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDEETRS VKASAQTDRV DLGTLRGYYN QSEDGSHTIQ
     LMFGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAAHAAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD REATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A11_HUMAN              Reviewed;         365 AA.
AC   P13746; O19605; O19606; Q29747; Q29835; Q5S3G1; Q9BCN0; Q9MYI5;
AC   Q9TQE9; Q9TQP6; Q9TQP7;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   20-JAN-2016, entry version 142.
DE   RecName: Full=HLA class I histocompatibility antigen, A-11 alpha chain;
DE   AltName: Full=MHC class I antigen A*11;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*11:01 AND A*11:02).
RX   PubMed=2460344;
RA   Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.;
RT   "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for
RT   trans-species mode of evolution.";
RL   EMBO J. 7:2765-2774(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*11:01 AND A*11:02).
RX   PubMed=8016845; DOI=10.1111/j.1399-0039.1994.tb02304.x;
RA   Lin L., Tokunaga K., Ishikawa Y., Bannai M., Kashiwase K., Kuwata S.,
RA   Akaza T., Tadokoro K., Shibata Y., Juji T.;
RT   "Sequence analysis of serological HLA-A11 split antigens, A11.1 and
RT   A11.2.";
RL   Tissue Antigens 43:78-82(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*11:05).
RX   PubMed=10395112; DOI=10.1034/j.1399-0039.1999.530612.x;
RA   Morrell G., Whalley J., Stewart A., Day S., Lewis L., Makar Y.,
RA   Ross J., Dunn P.P.;
RT   "Identification of an HLA-A11 serological variant and its
RT   characterization by sequencing based typing.";
RL   Tissue Antigens 53:591-594(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:03).
RC   TISSUE=Blood;
RX   PubMed=10703613; DOI=10.1034/j.1399-0039.2000.550113.x;
RA   Tijssen H.J., Sistermans E.A., van den Beucken M.J.G., Krausa P.,
RA   Joosten I.;
RT   "Complete sequence analysis of the A*1103 allele.";
RL   Tissue Antigens 55:68-70(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:03).
RC   TISSUE=Blood;
RX   PubMed=10885562; DOI=10.1034/j.1399-0039.2000.550504.x;
RA   Tijssen H.J., Sistermans E.A., Joosten I.;
RT   "A unique second donor splice site in the intron 5 sequence of the
RT   HLA-A*11 alleles results in a class I transcript encoding a molecule
RT   with an elongated cytoplasmic domain.";
RL   Tissue Antigens 55:422-428(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*11:05).
RX   PubMed=10852390; DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:07).
RX   PubMed=11703829; DOI=10.1034/j.1399-0039.2001.580309.x;
RA   Pyo C.W., Choi H.B., Han H., Hong Y.S., Kim T.G.;
RT   "Identification of HLA-A*11 variant (A*1107) in the Korean
RT   population.";
RL   Tissue Antigens 58:190-192(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:04) (ISOFORM 2).
RX   PubMed=17092262; DOI=10.1111/j.1399-0039.2006.00687.x;
RA   Sun Y., Liu S., Luo Y., Liang F., Xi Y.;
RT   "Identification and frequency of a novel HLA-A allele, A*110104.";
RL   Tissue Antigens 68:453-454(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:04) (ISOFORM 2).
RA   Xu L.-H., Chi X.-Y., Jia Q.-T., Li F.-Y., Zha Q.-B., He X.-H.;
RT   "Cloning of high frequency HLA-B alleles from Chinese population.";
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:04).
RA   Bettinotti M.P.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-365 (ALLELE A*11:01).
RX   PubMed=2437024; DOI=10.1007/BF00404694;
RA   Cowan E.P., Jelachich M.L., Biddison W.E., Coligan J.E.;
RT   "DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows
RT   identification of residues involved in epitopes recognized by
RT   antibodies and T cells.";
RL   Immunogenetics 25:241-250(1987).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*11:04).
RA   Chandanayingyong D., Sirikong M., Luangtrakool K., Srinak D.,
RA   Rungroung E., Bejchandra S.;
RT   "A11 alleles (A*11O4).";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, VARIANT [LARGE
RP   SCALE ANALYSIS] SER-345, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-352; SER-356
RP   AND SER-359, VARIANT [LARGE SCALE ANALYSIS] SER-345, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 25-299 (ALLELE A*11:01) IN
RP   COMPLEX WITH SARS NUCLEOCAPSID PEPTIDE, AND DISULFIDE BONDS.
RX   PubMed=16041067; DOI=10.1107/S0907444905013090;
RA   Blicher T., Kastrup J.S., Buus S., Gajhede M.;
RT   "High-resolution structure of HLA-A*1101 in complex with SARS
RT   nucleocapsid peptide.";
RL   Acta Crystallogr. D 61:1031-1040(2005).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-345, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-166, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13746-1; Sequence=Displayed;
CC       Name=2; Synonyms=Long;
CC         IsoId=P13746-2; Sequence=VSP_008099;
CC         Note=Only produced by allele A*1103.;
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-11 are known: A*11:01 (A-
CC       11E), A*11:02 (A-11K), A*11:03, A*11:04, A*11:05 and A*11:07. The
CC       sequence shown is that of A*11:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13111; CAA31503.1; -; mRNA.
DR   EMBL; X13112; CAA31504.1; -; mRNA.
DR   EMBL; D16841; BAA04117.1; -; mRNA.
DR   EMBL; D16842; BAA04118.1; -; mRNA.
DR   EMBL; AJ306733; CAC37336.1; -; Genomic_DNA.
DR   EMBL; X91399; CAA62745.1; -; mRNA.
DR   EMBL; Y17224; CAB38056.1; -; mRNA.
DR   EMBL; Y17224; CAB38057.1; -; mRNA.
DR   EMBL; AH007763; AAD33991.1; -; Genomic_DNA.
DR   EMBL; AF165065; AAF25781.1; -; mRNA.
DR   EMBL; DQ336694; ABC59611.1; -; mRNA.
DR   EMBL; AY786586; AAV53344.1; -; mRNA.
DR   EMBL; AY786587; AAV53345.1; -; mRNA.
DR   EMBL; U50574; AAB60406.1; -; mRNA.
DR   EMBL; AH003070; AAA65449.1; -; Genomic_DNA.
DR   EMBL; AH005647; AAB87052.1; -; Genomic_DNA.
DR   EMBL; AH005646; AAB87051.1; -; Genomic_DNA.
DR   PIR; I83063; I83063.
DR   PIR; S03536; A47636.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   PDB; 1Q94; X-ray; 2.40 A; A/D=25-299.
DR   PDB; 1QVO; X-ray; 2.22 A; A/D=25-299.
DR   PDB; 1X7Q; X-ray; 1.45 A; A=25-299.
DR   PDB; 2HN7; X-ray; 1.60 A; A=25-299.
DR   PDB; 4BEO; X-ray; 2.43 A; A/C=25-299.
DR   PDB; 4MJ5; X-ray; 2.40 A; A=25-298.
DR   PDB; 4MJ6; X-ray; 2.57 A; A=25-298.
DR   PDB; 4N8V; X-ray; 2.50 A; A/D=25-298.
DR   PDB; 4UQ2; X-ray; 2.43 A; A/C=25-299.
DR   PDBsum; 1Q94; -.
DR   PDBsum; 1QVO; -.
DR   PDBsum; 1X7Q; -.
DR   PDBsum; 2HN7; -.
DR   PDBsum; 4BEO; -.
DR   PDBsum; 4MJ5; -.
DR   PDBsum; 4MJ6; -.
DR   PDBsum; 4N8V; -.
DR   PDBsum; 4UQ2; -.
DR   ProteinModelPortal; P13746; -.
DR   SMR; P13746; 25-299.
DR   IntAct; P13746; 1.
DR   STRING; 9606.ENSP00000366005; -.
DR   iPTMnet; P13746; -.
DR   DMDM; 122157; -.
DR   MaxQB; P13746; -.
DR   PaxDb; P13746; -.
DR   PRIDE; P13746; -.
DR   Ensembl; ENST00000376809; ENSP00000366005; ENSG00000206503.
DR   Ensembl; ENST00000396634; ENSP00000379873; ENSG00000206503.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P13746; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   EvolutionaryTrace; P13746; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; P13746; -.
DR   CleanEx; HS_HLA-A; -.
DR   ExpressionAtlas; P13746; baseline and differential.
DR   Genevisible; P13746; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; IDA:UniProtKB.
DR   GO; GO:0046977; F:TAP binding; IDA:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Host-virus interaction; Immunity; Membrane; MHC I;
KW   Phosphoprotein; Polymorphism; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-11 alpha chain.
FT                                /FTId=PRO_0000018816.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:16041067}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:16041067}.
FT   VAR_SEQ     337    337       S -> SGGEGVK (in isoform 2).
FT                                {ECO:0000303|PubMed:17092262,
FT                                ECO:0000303|Ref.9}.
FT                                /FTId=VSP_008099.
FT   VARIANT      43     43       E -> K (in allele A*11:02).
FT                                /FTId=VAR_004353.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056254.
FT   VARIANT      94     94       Q -> H (in dbSNP:rs1059463).
FT                                /FTId=VAR_056255.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056256.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056257.
FT   VARIANT     133    133       F -> L (in allele A*11:07;
FT                                dbSNP:rs1059488).
FT                                /FTId=VAR_016731.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056258.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                {ECO:0000244|PubMed:21269460}.
FT                                /FTId=VAR_056259.
FT   VARIANT     168    168       K -> E (in allele A*11:05).
FT                                /FTId=VAR_016732.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_056260.
FT   VARIANT     175    175       H -> R (in allele A*11:03).
FT                                /FTId=VAR_016733.
FT   VARIANT     176    176       A -> E (in allele A*11:03).
FT                                /FTId=VAR_016734.
FT   VARIANT     187    187       R -> T (in allele A*11:04).
FT                                /FTId=VAR_016735.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056261.
FT   VARIANT     345    345       T -> S (in allele A*11:05).
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:24275569}.
FT                                /FTId=VAR_016736.
FT   STRAND       27     36       {ECO:0000244|PDB:1X7Q}.
FT   STRAND       41     43       {ECO:0000244|PDB:1X7Q}.
FT   STRAND       45     52       {ECO:0000244|PDB:1X7Q}.
FT   STRAND       55     61       {ECO:0000244|PDB:1X7Q}.
FT   STRAND       64     66       {ECO:0000244|PDB:1X7Q}.
FT   HELIX        74     76       {ECO:0000244|PDB:1X7Q}.
FT   HELIX        81    108       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      113    115       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      118    127       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      133    142       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      145    150       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      157    159       {ECO:0000244|PDB:1X7Q}.
FT   HELIX       162    173       {ECO:0000244|PDB:1X7Q}.
FT   HELIX       176    185       {ECO:0000244|PDB:1X7Q}.
FT   HELIX       187    198       {ECO:0000244|PDB:1X7Q}.
FT   HELIX       200    203       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      210    217       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      219    235       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      238    243       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      246    248       {ECO:0000244|PDB:2HN7}.
FT   STRAND      252    254       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      261    263       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      265    274       {ECO:0000244|PDB:1X7Q}.
FT   HELIX       278    280       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      281    286       {ECO:0000244|PDB:1X7Q}.
FT   STRAND      288    292       {ECO:0000244|PDB:1QVO}.
FT   STRAND      294    297       {ECO:0000244|PDB:1X7Q}.
SQ   SEQUENCE   365 AA;  40937 MW;  FE449CE2D4BF6CC5 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHAAEQQ
     RAYLEGRCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A23_HUMAN              Reviewed;         365 AA.
AC   P30447; Q9TQF1; Q9TQF8; Q9TQG5; Q9TQM6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   20-JAN-2016, entry version 129.
DE   RecName: Full=HLA class I histocompatibility antigen, A-23 alpha chain;
DE   AltName: Full=HLA class I histocompatibility antigen, A-9 alpha chain;
DE   AltName: Full=MHC class I antigen A*23;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*23:01).
RX   PubMed=1729171; DOI=10.1007/BF00216625;
RA   Little A.-M., Madrigal J.A., Parham P.;
RT   "Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3.";
RL   Immunogenetics 35:41-45(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*23:02 AND A*23:03).
RX   PubMed=10852390; DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*23:04 AND A*23:05).
RX   PubMed=11169246; DOI=10.1034/j.1399-0039.2000.560610.x;
RA   Steiner N.K., Edson S.M., Mitton W., Ng J., Hartzman R.J.,
RA   Hurley C.K.;
RT   "Seven novel HLA-A alleles carry previously observed polymorphisms.";
RL   Tissue Antigens 56:551-552(2000).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-352; SER-356
RP   AND SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-23 are known: A*23:01,
CC       A*23:02, A*23:03, A*23:04 and A*23:05. The sequence shown is that
CC       of A*23:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64742; AAA03662.1; -; mRNA.
DR   EMBL; AH007754; AAD33736.1; -; Genomic_DNA.
DR   EMBL; AH007619; AAD28171.1; -; Genomic_DNA.
DR   EMBL; AH007540; AAD22272.1; -; Genomic_DNA.
DR   EMBL; AH007726; AAD31878.1; -; Genomic_DNA.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   ProteinModelPortal; P30447; -.
DR   SMR; P30447; 25-298.
DR   iPTMnet; P30447; -.
DR   DMDM; 231359; -.
DR   MaxQB; P30447; -.
DR   PRIDE; P30447; -.
DR   Ensembl; ENST00000454091; ENSP00000410645; ENSG00000223980.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30447; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-23 alpha chain.
FT                                /FTId=PRO_0000018817.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      31     31       Y -> C (in allele A*23:05).
FT                                /FTId=VAR_016606.
FT   VARIANT     151    151       K -> N (in allele A*23:03).
FT                                /FTId=VAR_016607.
FT   VARIANT     180    180       L -> W (in allele A*23:02).
FT                                /FTId=VAR_016608.
FT   VARIANT     190    191       DG -> EW (in allele A*23:04).
FT                                /FTId=VAR_016609.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056262.
SQ   SEQUENCE   365 AA;  40733 MW;  C372DE503BF393D0 CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDEETGK VKAHSQTDRE NLRIALRYYN QSEAGSHTLQ
     MMFGCDVGSD GRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTVHIVG IIAGLVLLGA VITGAVVAAV MWRRNSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A24_HUMAN              Reviewed;         365 AA.
AC   P05534; P30448; P30449; Q29908; Q29909; Q29910; Q95355;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2003, sequence version 2.
DT   20-JAN-2016, entry version 163.
DE   RecName: Full=HLA class I histocompatibility antigen, A-24 alpha chain;
DE   AltName: Full=Aw-24;
DE   AltName: Full=HLA class I histocompatibility antigen, A-9 alpha chain;
DE   AltName: Full=MHC class I antigen A*24;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*24:01).
RX   PubMed=2987115; DOI=10.1007/BF00430931;
RA   N'Guyen C., Sodoyer R., Trucy J., Strachan T., Jordan B.R.;
RT   "The HLA-AW24 gene: sequence, surroundings and comparison with the
RT   HLA-A2 and HLA-A3 genes.";
RL   Immunogenetics 21:479-489(1985).
RN   [2]
RP   SEQUENCE REVISION.
RA   Jordan B.R.;
RL   Submitted (JUL-1988) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELES A*24:02 AND
RP   A*24:03).
RX   PubMed=1729171; DOI=10.1007/BF00216625;
RA   Little A.-M., Madrigal J.A., Parham P.;
RT   "Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3.";
RL   Immunogenetics 35:41-45(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*24:02).
RX   PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*24:02).
RX   PubMed=9349616; DOI=10.1111/j.1399-0039.1997.tb02884.x;
RA   Laforet M., Froelich N., Parissiadis A., Bausinger H., Pfeiffer B.,
RA   Tongio M.M.;
RT   "An intronic mutation responsible for a low level of expression of an
RT   HLA-A*24 allele.";
RL   Tissue Antigens 50:340-346(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*24:08).
RC   TISSUE=Blood;
RA   Kashiwase K., Tokunaga K., Ishikawa Y., Qiu L., Furuya M.,
RA   Sawanaka K., Akaza T., Tadokoro K., Juji T.;
RT   "Sequence analysis of a serological subtype, HLA-A9HH, observed in
RT   Japanese and the confirmatory sequence of A*2408.";
RL   MHC 3:9-14(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-337 (ALLELE A*24:29).
RA   Dunn P.;
RT   "Confirmation of the sequence of HLA-A*2429 allele found in a
RT   potential bone marrow donor.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*24:10).
RC   TISSUE=Blood;
RX   PubMed=9008316; DOI=10.1111/j.1399-0039.1996.tb02697.x;
RA   Gao X., Matheson B.;
RT   "A novel HLA-A*24 (A*2410) identified in a Javanese population.";
RL   Tissue Antigens 48:711-713(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES A*24:06; A*24:13
RP   AND A*24:14).
RC   TISSUE=Blood;
RX   PubMed=9271829; DOI=10.1111/j.1399-0039.1997.tb02858.x;
RA   Gao X., Lester S., Matheson B., Boettcher B., McCluskey J.;
RT   "Three newly identified A*24 alleles: A*2406, A*2413 and A*2414.";
RL   Tissue Antigens 50:192-196(1997).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-352; SER-356
RP   AND SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.39 ANGSTROMS) OF 25-298 (ALLELE A*24:02) IN
RP   COMPLEX WITH B2M AND CD8, AND DISULFIDE BONDS.
RX   PubMed=21645925; DOI=10.1016/j.molimm.2011.05.009;
RA   Shi Y., Qi J., Iwamoto A., Gao G.F.;
RT   "Plasticity of human CD8alphaalpha binding to peptide-HLA-A*2402.";
RL   Mol. Immunol. 48:2198-2202(2011).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] TRP-180, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-24 are known: A*24:01,
CC       A*24:02, A*24:03, A*24:06, A*24:08 (A9HH), A*24:10 (A*24JV),
CC       A*24:13 (A*24YM), A*24:14 (A*24SA) and A*24:29. Allele A*24:02 is
CC       represented in all major racial groups. Allele A*24:06 and allele
CC       A*24:13 are found in the Australian Aboriginal population. Allele
CC       A*24:14 is found in individuals of South American descent. The
CC       sequence shown is that of A*24:02. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15497; AAA59611.1; -; Genomic_DNA.
DR   EMBL; M64740; AAA59600.1; -; mRNA.
DR   EMBL; M64741; AAA59601.1; -; Genomic_DNA.
DR   EMBL; Z72422; CAA96532.1; -; Genomic_DNA.
DR   EMBL; D83516; BAA11936.1; -; mRNA.
DR   EMBL; U37111; AAA83264.1; -; Genomic_DNA.
DR   EMBL; U37110; AAA83264.1; JOINED; Genomic_DNA.
DR   EMBL; U37113; AAA83265.1; -; Genomic_DNA.
DR   EMBL; U37112; AAA83265.1; JOINED; Genomic_DNA.
DR   EMBL; AH004915; AAB40048.1; -; Genomic_DNA.
DR   EMBL; AH005378; AAB60651.1; -; Genomic_DNA.
DR   PIR; I54416; I54416.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   PDB; 2BCK; X-ray; 2.80 A; A/D=25-300.
DR   PDB; 3I6L; X-ray; 2.40 A; D=25-298.
DR   PDB; 3NFN; X-ray; 2.39 A; A=25-298.
DR   PDB; 3QZW; X-ray; 2.80 A; A/D=25-298.
DR   PDB; 3VXM; X-ray; 2.50 A; A=25-298.
DR   PDB; 3VXN; X-ray; 1.95 A; A=25-298.
DR   PDB; 3VXO; X-ray; 2.61 A; A/D=25-298.
DR   PDB; 3VXP; X-ray; 2.50 A; A/D=25-298.
DR   PDB; 3VXR; X-ray; 2.40 A; A=25-298.
DR   PDB; 3VXS; X-ray; 1.80 A; A=25-298.
DR   PDB; 3VXU; X-ray; 2.70 A; A/F=25-298.
DR   PDB; 3W0W; X-ray; 2.60 A; A=25-298.
DR   PDB; 3WL9; X-ray; 1.66 A; A=25-298.
DR   PDB; 3WLB; X-ray; 2.00 A; A=25-298.
DR   PDB; 4F7M; X-ray; 2.40 A; A/D=25-298.
DR   PDB; 4F7P; X-ray; 1.90 A; A=25-298.
DR   PDB; 4F7T; X-ray; 1.70 A; A/D=25-298.
DR   PDB; 4WU5; X-ray; 2.40 A; A/D=25-298.
DR   PDB; 4WU7; X-ray; 2.30 A; A/D=25-298.
DR   PDBsum; 2BCK; -.
DR   PDBsum; 3I6L; -.
DR   PDBsum; 3NFN; -.
DR   PDBsum; 3QZW; -.
DR   PDBsum; 3VXM; -.
DR   PDBsum; 3VXN; -.
DR   PDBsum; 3VXO; -.
DR   PDBsum; 3VXP; -.
DR   PDBsum; 3VXR; -.
DR   PDBsum; 3VXS; -.
DR   PDBsum; 3VXU; -.
DR   PDBsum; 3W0W; -.
DR   PDBsum; 3WL9; -.
DR   PDBsum; 3WLB; -.
DR   PDBsum; 4F7M; -.
DR   PDBsum; 4F7P; -.
DR   PDBsum; 4F7T; -.
DR   PDBsum; 4WU5; -.
DR   PDBsum; 4WU7; -.
DR   ProteinModelPortal; P05534; -.
DR   SMR; P05534; 25-298.
DR   iPTMnet; P05534; -.
DR   DMDM; 32363482; -.
DR   MaxQB; P05534; -.
DR   PRIDE; P05534; -.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   GeneCards; HLA-A; -.
DR   H-InvDB; HIX0165910; -.
DR   H-InvDB; HIX0165954; -.
DR   H-InvDB; HIX0166079; -.
DR   H-InvDB; HIX0166152; -.
DR   H-InvDB; HIX0166432; -.
DR   H-InvDB; HIX0166685; -.
DR   H-InvDB; HIX0166954; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P05534; -.
DR   HOVERGEN; HBG016709; -.
DR   PhylomeDB; P05534; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   EvolutionaryTrace; P05534; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0046977; F:TAP binding; IDA:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-24 alpha chain.
FT                                /FTId=PRO_0000018818.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:21645925}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:21645925}.
FT   VARIANT       5      5       A -> G (in allele A*24:01).
FT                                {ECO:0000269|PubMed:2987115}.
FT                                /FTId=VAR_004354.
FT   VARIANT      27     27       H -> Q (in allele A*24:08;
FT                                dbSNP:rs41541319). {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_004355.
FT   VARIANT      86     86       E -> G (in allele A*24:08).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_004356.
FT   VARIANT      89     89       G -> R (in allele A*24:08 and allele
FT                                A*24:29). {ECO:0000269|Ref.6,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_004357.
FT   VARIANT     119    119       L -> V (in allele A*24:14).
FT                                {ECO:0000269|PubMed:9271829}.
FT                                /FTId=VAR_015765.
FT   VARIANT     121    121       M -> R (in allele A*24:14).
FT                                {ECO:0000269|PubMed:9271829}.
FT                                /FTId=VAR_015766.
FT   VARIANT     123    123       F -> Y (in allele A*24:14).
FT                                {ECO:0000269|PubMed:9271829}.
FT                                /FTId=VAR_015767.
FT   VARIANT     131    131       G -> W (in allele A*24:14).
FT                                {ECO:0000269|PubMed:9271829}.
FT                                /FTId=VAR_015768.
FT   VARIANT     180    180       Q -> L (in allele A*24:13).
FT                                {ECO:0000269|PubMed:9271829}.
FT                                /FTId=VAR_015769.
FT   VARIANT     180    180       Q -> W (in allele A*24:06; requires 2
FT                                nucleotide substitutions).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:9271829}.
FT                                /FTId=VAR_004358.
FT   VARIANT     187    187       T -> R (in allele A*24:10).
FT                                {ECO:0000269|PubMed:9008316}.
FT                                /FTId=VAR_015770.
FT   VARIANT     190    191       DG -> EW (in allele A*24:03 and allele
FT                                A*24:10). {ECO:0000269|PubMed:1729171,
FT                                ECO:0000269|PubMed:9008316}.
FT                                /FTId=VAR_004359.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056263.
FT   VARIANT     206    206       T -> A (in allele A*24:01).
FT                                {ECO:0000269|PubMed:2987115}.
FT                                /FTId=VAR_004360.
FT   STRAND       27     36       {ECO:0000244|PDB:3WL9}.
FT   STRAND       41     43       {ECO:0000244|PDB:3WL9}.
FT   STRAND       45     52       {ECO:0000244|PDB:3WL9}.
FT   STRAND       55     61       {ECO:0000244|PDB:3WL9}.
FT   STRAND       64     66       {ECO:0000244|PDB:3WL9}.
FT   STRAND       70     73       {ECO:0000244|PDB:4F7T}.
FT   HELIX        74     76       {ECO:0000244|PDB:3WL9}.
FT   HELIX        81    109       {ECO:0000244|PDB:3WL9}.
FT   STRAND      113    115       {ECO:0000244|PDB:3VXS}.
FT   STRAND      118    127       {ECO:0000244|PDB:3WL9}.
FT   STRAND      133    142       {ECO:0000244|PDB:3WL9}.
FT   STRAND      145    150       {ECO:0000244|PDB:3WL9}.
FT   STRAND      157    159       {ECO:0000244|PDB:3WL9}.
FT   HELIX       162    173       {ECO:0000244|PDB:3WL9}.
FT   HELIX       176    185       {ECO:0000244|PDB:3WL9}.
FT   HELIX       187    198       {ECO:0000244|PDB:3WL9}.
FT   HELIX       200    203       {ECO:0000244|PDB:3WL9}.
FT   STRAND      210    235       {ECO:0000244|PDB:3WL9}.
FT   STRAND      238    243       {ECO:0000244|PDB:3WL9}.
FT   STRAND      246    248       {ECO:0000244|PDB:3WLB}.
FT   HELIX       249    251       {ECO:0000244|PDB:3WL9}.
FT   STRAND      252    254       {ECO:0000244|PDB:4F7T}.
FT   STRAND      261    263       {ECO:0000244|PDB:3WL9}.
FT   STRAND      265    274       {ECO:0000244|PDB:3WL9}.
FT   HELIX       278    280       {ECO:0000244|PDB:3WL9}.
FT   STRAND      281    286       {ECO:0000244|PDB:3WL9}.
FT   STRAND      290    292       {ECO:0000244|PDB:4F7M}.
FT   STRAND      294    297       {ECO:0000244|PDB:3WL9}.
FT   STRAND      298    300       {ECO:0000244|PDB:2BCK}.
SQ   SEQUENCE   365 AA;  40689 MW;  D33684D126F98EC3 CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDEETGK VKAHSQTDRE NLRIALRYYN QSEAGSHTLQ
     MMFGCDVGSD GRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQITKRK WEAAHVAEQQ
     RAYLEGTCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTVPIVG IIAGLVLLGA VITGAVVAAV MWRRNSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A29_HUMAN              Reviewed;         365 AA.
AC   P30512; O02955; O19687; O98011; P30451; P79562;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   20-JAN-2016, entry version 138.
DE   RecName: Full=HLA class I histocompatibility antigen, A-29 alpha chain;
DE   AltName: Full=Aw-19;
DE   AltName: Full=MHC class I antigen A*29;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*29:01).
RX   PubMed=2461903; DOI=10.1007/BF02341610;
RA   Trapani J.A., Mizuno S., Kang S.H., Yang S.Y., Dupont B.;
RT   "Molecular mapping of a new public HLA class I epitope shared by all
RT   HLA-B and HLA-C antigens and defined by a monoclonal antibody.";
RL   Immunogenetics 29:25-32(1989).
RN   [2]
RP   SEQUENCE REVISION TO 345.
RA   Yang S.Y.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*29:01).
RA   Szmania S., Baxter-Lowe L.A.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*29:02).
RX   PubMed=1782566;
RA   Tabary T., Prochnicka-Chalufour A., Cornillet P., Lehoang P.,
RA   Betuel H., Cohen H.M.;
RT   "HLA-A29 sub-types and 'Birdshot' choroido-retinopathy susceptibility:
RT   a possible 'resistance motif' in the HLA-A29.1 molecule.";
RL   C. R. Acad. Sci. III, Sci. Vie 313:599-605(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELE A*29:03).
RX   PubMed=9459513; DOI=10.1111/j.1399-0039.1998.tb02956.x;
RA   Prokupek B., Dunn P., Ross J., Jordan F., Holman R., Madrigal J.A.,
RA   Little A.-M.;
RT   "HLA-A*2903 expresses an epitope shared with HLA-A*8001.";
RL   Tissue Antigens 51:115-118(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*29:04).
RX   PubMed=11260503; DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; TYR-344; SER-345;
RP   SER-349; SER-352; SER-356 AND SER-359, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-29 are known: A*29:01
CC       (A29.1), A*29:02 (A29.2), A*29:03 and A*29:04. The sequence shown
CC       is that of A*29:01. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M23739; AAB47873.1; -; mRNA.
DR   EMBL; U83415; AAB53373.1; -; mRNA.
DR   EMBL; X60108; CAA42702.1; -; mRNA.
DR   EMBL; AJ000661; CAA04209.1; -; mRNA.
DR   EMBL; Y09218; CAA70419.1; -; Genomic_DNA.
DR   EMBL; AH007203; AAD02224.1; -; Genomic_DNA.
DR   PIR; A45847; A45847.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   ProteinModelPortal; P30512; -.
DR   SMR; P30512; 25-294.
DR   IntAct; P30512; 7.
DR   iPTMnet; P30512; -.
DR   DMDM; 2851401; -.
DR   PRIDE; P30512; -.
DR   Ensembl; ENST00000456012; ENSP00000408986; ENSG00000231834.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30512; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-29 alpha chain.
FT                                /FTId=PRO_0000018821.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      90     90       N -> H (in allele A*29:04).
FT                                {ECO:0000269|PubMed:11260503}.
FT                                /FTId=VAR_016347.
FT   VARIANT     126    126       H -> D (in allele A*29:02, allele A*29:03
FT                                and allele A*29:04).
FT                                {ECO:0000269|PubMed:11260503,
FT                                ECO:0000269|PubMed:1782566,
FT                                ECO:0000269|PubMed:9459513}.
FT                                /FTId=VAR_004365.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_056266.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056267.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056268.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056269.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056270.
FT   VARIANT     190    191       EW -> DG (in allele A*29:03).
FT                                {ECO:0000269|PubMed:9459513}.
FT                                /FTId=VAR_010372.
SQ   SEQUENCE   365 AA;  40863 MW;  56E4B9039B3C783C CRC64;
     MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFTTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDLQTRN VKAQSQTDRA NLGTLRGYYN QSEAGSHTIQ
     MMYGCHVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A30_HUMAN              Reviewed;         365 AA.
AC   P16188; O19598; O62921; P30452; Q9UIP7;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   17-FEB-2016, entry version 133.
DE   RecName: Full=HLA class I histocompatibility antigen, A-30 alpha chain;
DE   AltName: Full=MHC class I antigen A*30;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*30:01).
RX   PubMed=2478623;
RA   Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.;
RT   "Molecular analysis of the serologically defined HLA-Aw19 antigens. A
RT   genetically distinct family of HLA-A antigens comprising A29, A31,
RT   A32, and Aw33, but probably not A30.";
RL   J. Immunol. 143:3371-3378(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*30:01).
RX   PubMed=7871528; DOI=10.1111/j.1399-0039.1994.tb02393.x;
RA   Olerup O., Daniels T.J., Baxter-Lowe L.;
RT   "Correct sequence of the A*3001 allele obtained by PCR-SSP typing and
RT   automated nucleotide sequencing.";
RL   Tissue Antigens 44:265-267(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*30:02).
RX   PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-279 (ALLELE A*30:03).
RX   PubMed=8458735; DOI=10.1016/0198-8859(93)90004-K;
RA   Choo S.Y., Starling G.C., Anasetti C., Hansen J.A.;
RT   "Selection of an unrelated donor for marrow transplantation
RT   facilitated by the molecular characterization of a novel HLA-A
RT   allele.";
RL   Hum. Immunol. 36:20-26(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*30:04).
RX   PubMed=8522453; DOI=10.1016/0198-8859(95)00046-7;
RA   Krausa P., Carcassi C., Orru S., Bodmer J.G., Browning M.J., Contu L.;
RT   "Defining the allelic variants of HLA-A30 in the Sardinian population
RT   using amplification refractory mutation system -- polymerase chain
RT   reaction.";
RL   Hum. Immunol. 44:35-42(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 26-206 (ALLELE A*30:04).
RX   PubMed=8838350; DOI=10.1111/j.1399-0039.1995.tb03133.x;
RA   Lienert K., Russ G., Bennett G., Gao X., McCluskey J.;
RT   "HLA-A*3004: a new A30 allele identified in an Australian Caucasoid
RT   population.";
RL   Tissue Antigens 46:394-397(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-205 (ALLELE A*30:04).
RX   PubMed=8560452; DOI=10.1111/j.1399-0039.1995.tb02500.x;
RA   Blasczyk R., Wehling J., Paessler M., Hahn U., Huhn D., Salama A.;
RT   "A novel HLA-A30 allele (A*3004) identified by single-strand
RT   conformation polymorphism analysis and confirmed by solid-phase
RT   sequencing.";
RL   Tissue Antigens 46:322-326(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*30:06).
RX   PubMed=11098929; DOI=10.1034/j.1399-0039.2000.560401.x;
RA   Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H.,
RA   Hurley C.K.;
RT   "Diversity is demonstrated in class I HLA-A and HLA-B alleles in
RT   Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-
RT   B*1403, *4016, *4703.";
RL   Tissue Antigens 56:291-302(2000).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*30:07).
RX   PubMed=10852390; DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [10]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*30:08).
RX   PubMed=11169261; DOI=10.1034/j.1399-0039.2001.057001070.x;
RA   Cox S.T., Mcwhinnie A.J., Koester R.P., Heine U., Holman R.,
RA   Madrigal A.J., Little A.-M.;
RT   "Further diversity at HLA-A and -B loci identified in Afro-Caribbean
RT   potential bone marrow donors.";
RL   Tissue Antigens 57:70-72(2001).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352; SER-356 AND
RP   SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] GLY-80, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] GLY-80, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-30 are known: A*30:01
CC       (A30.3), A*30:02, A*30:03, A*30:04 (A30W7), A*30:06, A*30:07 and
CC       A*30:08. The sequence shown is that of A*30:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30576; AAA59612.1; -; Genomic_DNA.
DR   EMBL; U07234; AAA70162.1; -; mRNA.
DR   EMBL; X61702; CAA43871.1; -; mRNA.
DR   EMBL; M93657; AAA58650.1; -; Genomic_DNA.
DR   EMBL; Z34921; CAA84401.1; -; Genomic_DNA.
DR   EMBL; AH005195; AAB53658.1; -; Genomic_DNA.
DR   EMBL; U24261; AAB50434.1; -; mRNA.
DR   EMBL; X83770; CAA58723.1; -; Genomic_DNA.
DR   EMBL; X83771; CAA58724.1; -; Genomic_DNA.
DR   EMBL; AH006045; AAC14191.1; -; Genomic_DNA.
DR   EMBL; AH006148; AAC18600.1; -; Genomic_DNA.
DR   EMBL; AJ249308; CAB57306.1; -; Genomic_DNA.
DR   EMBL; AJ249309; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249310; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249311; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249312; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249313; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249314; CAB57306.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249315; CAB57306.1; JOINED; Genomic_DNA.
DR   PIR; I38519; I38519.
DR   PIR; I54307; I54307.
DR   PIR; I56039; I56039.
DR   ProteinModelPortal; P16188; -.
DR   SMR; P16188; 25-298.
DR   IntAct; P16188; 1.
DR   STRING; 9606.ENSP00000366005; -.
DR   iPTMnet; P16188; -.
DR   SwissPalm; P16188; -.
DR   DMDM; 1345596; -.
DR   MaxQB; P16188; -.
DR   PaxDb; P16188; -.
DR   PRIDE; P16188; -.
DR   Ensembl; ENST00000376809; ENSP00000366005; ENSG00000206503.
DR   Ensembl; ENST00000396634; ENSP00000379873; ENSG00000206503.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P16188; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   TreeFam; TF336617; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   NextBio; 35537752; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; P16188; -.
DR   CleanEx; HS_HLA-A; -.
DR   ExpressionAtlas; P16188; baseline and differential.
DR   Genevisible; P16188; HS.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0046977; F:TAP binding; IDA:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-30 alpha chain.
FT                                /FTId=PRO_0000018822.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      21     21       H -> Q (in allele A*30:02, allele A*30:04
FT                                and allele A*30:08).
FT                                /FTId=VAR_004366.
FT   VARIANT      33     33       S -> Y (in allele A*30:08).
FT                                /FTId=VAR_010284.
FT   VARIANT      55     55       T -> A (in allele A*30:06).
FT                                /FTId=VAR_016653.
FT   VARIANT      80     80       R -> G (in allele A*30:03).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000244|PubMed:25944712}.
FT                                /FTId=VAR_004367.
FT   VARIANT      86     86       Q -> E (in allele A*30:07).
FT                                /FTId=VAR_016738.
FT   VARIANT      89     90       RN -> GK (in allele A*30:07).
FT                                /FTId=VAR_016739.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056271.
FT   VARIANT      94     94       Q -> H (in allele A*30:02, allele
FT                                A*30:03, allele A*30:04, allele A*30:06
FT                                and allele A*30:07; dbSNP:rs1059463).
FT                                /FTId=VAR_004368.
FT   VARIANT     100    101       VD -> EN (in allele A*30:02, allele
FT                                A*30:03, allele A*30:04, allele A*30:06
FT                                and allele A*30:07).
FT                                /FTId=VAR_004369.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056272.
FT   VARIANT     121    121       I -> M (in dbSNP:rs1136695).
FT                                /FTId=VAR_056273.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_056274.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056275.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056276.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056277.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056278.
FT   VARIANT     175    176       RW -> HV (in allele A*30:04 and allele
FT                                A*30:06).
FT                                /FTId=VAR_004370.
FT   VARIANT     176    176       W -> R (in allele A*30:02, allele A*30:03
FT                                and allele A*30:07).
FT                                /FTId=VAR_004371.
FT   VARIANT     180    180       L -> W (in allele A*30:04 and allele
FT                                A*30:06).
FT                                /FTId=VAR_004372.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056279.
FT   CONFLICT     33     33       S -> F (in Ref. 1; AAA59612).
FT                                {ECO:0000305}.
SQ   SEQUENCE   365 AA;  40905 MW;  521166D95FB1DC28 CRC64;
     MAVMAPRTLL LLLSGALALT HTWAGSHSMR YFSTSVSRPG SGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQER PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYEQH AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARWAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A32_HUMAN              Reviewed;         365 AA.
AC   P10314; O77937; Q29838; Q8MHN9; Q9MYE9; Q9MYG5; Q9TQF5; Q9TQF9;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   20-JAN-2016, entry version 140.
DE   RecName: Full=HLA class I histocompatibility antigen, A-32 alpha chain;
DE   AltName: Full=MHC class I antigen A*32;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*32:01).
RA   Domena J.D.;
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 25-298 (ALLELE A*32:01).
RX   PubMed=2431040;
RA   Wan A.M., Ennis P., Parham P., Holmes N.;
RT   "The primary structure of HLA-A32 suggests a region involved in
RT   formation of the Bw4/Bw6 epitopes.";
RL   J. Immunol. 137:3671-3674(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*32:02).
RC   TISSUE=Blood;
RX   PubMed=8881042; DOI=10.1007/s002510050171;
RA   Zino E., Severini G.M., Mazzi B., Bordignon C., Benazzi E.,
RA   Fleischhauer K.;
RT   "Sequencing of a new HLA-A*32 subtype (A*3202).";
RL   Immunogenetics 45:76-77(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*32:03 AND A*32:04).
RX   PubMed=10852390; DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*32:03).
RA   Kanaan C., Hepner J., Thornton A.;
RT   "Confirmatory exon 2 and 3 sequence for HLA-A*3203.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*32:05).
RA   Bettinotti M.P., Hadzikadic L., Adams S., Marincola F.M.;
RT   "A new HLA A-32 allele.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*32:06).
RA   Jones P.F., Hurley C.K.;
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; TYR-344; SER-345;
RP   SER-349; SER-352; SER-356 AND SER-359, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-185, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-185, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-32 are known: A*32:01,
CC       A*32:02, A*32:03, A*32:04, A*32:05 and A*32:06. The sequence shown
CC       is that of A*32:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03907; AAA03605.1; -; mRNA.
DR   EMBL; X97120; CAA65786.1; -; mRNA.
DR   EMBL; AH006303; AAC26020.1; -; Genomic_DNA.
DR   EMBL; AH007756; AAD33738.1; -; Genomic_DNA.
DR   EMBL; AH007758; AAD33849.1; -; Genomic_DNA.
DR   EMBL; AH011735; AAM78538.1; -; Genomic_DNA.
DR   EMBL; AF217560; AAF28733.1; -; mRNA.
DR   EMBL; AH009113; AAF29554.1; -; Genomic_DNA.
DR   PIR; A26088; HLHU32.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   ProteinModelPortal; P10314; -.
DR   SMR; P10314; 25-294.
DR   iPTMnet; P10314; -.
DR   DMDM; 1168210; -.
DR   PRIDE; P10314; -.
DR   Ensembl; ENST00000454091; ENSP00000410645; ENSG00000223980.
DR   Ensembl; ENST00000552493; ENSP00000448992; ENSG00000223980.
DR   UCSC; uc011jeb.2; human.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P10314; -.
DR   HOVERGEN; HBG016709; -.
DR   OMA; AQTHREN; -.
DR   PhylomeDB; P10314; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0046977; F:TAP binding; IDA:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-32 alpha chain.
FT                                /FTId=PRO_0000018824.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      89     90       RN -> GK (in allele A*32:05).
FT                                /FTId=VAR_016656.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056283.
FT   VARIANT     101    101       S -> N (in allele A*32:03).
FT                                /FTId=VAR_016657.
FT   VARIANT     121    121       M -> I (in allele A*32:04).
FT                                /FTId=VAR_016831.
FT   VARIANT     129    129       P -> S (in allele A*32:04).
FT                                /FTId=VAR_016832.
FT   VARIANT     133    133       L -> F (in allele A*32:04).
FT                                /FTId=VAR_016833.
FT   VARIANT     138    138       Q -> R (in allele A*32:04).
FT                                /FTId=VAR_016834.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056284.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056285.
FT   VARIANT     168    168       Q -> K (in allele A*32:04).
FT                                /FTId=VAR_016835.
FT   VARIANT     175    175       R -> H (in allele A*32:02, allele A*32:04
FT                                and allele A*32:06).
FT                                /FTId=VAR_004373.
FT   VARIANT     176    176       V -> E (in allele A*32:04).
FT                                /FTId=VAR_016836.
FT   VARIANT     180    180       L -> Q (in allele A*32:02).
FT                                /FTId=VAR_004374.
FT   VARIANT     185    185       E -> D (in allele A*32:04).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000244|PubMed:25944712}.
FT                                /FTId=VAR_016837.
SQ   SEQUENCE   365 AA;  41048 MW;  BF7AF225329E0319 CRC64;
     MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAHSQTDRE SLRIALRYYN QSEAGSHTIQ
     MMYGCDVGPD GRLLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA MFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A34_HUMAN              Reviewed;         365 AA.
AC   P30453; P30454;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   17-FEB-2016, entry version 129.
DE   RecName: Full=HLA class I histocompatibility antigen, A-34 alpha chain;
DE   AltName: Full=Aw-34;
DE   AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain;
DE   AltName: Full=MHC class I antigen A*34;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*34:01 AND A*34:02).
RX   PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   Martell R.W., du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by
RT   interallelic conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*34:01 AND A*34:02).
RX   PubMed=8475492; DOI=10.1111/j.1399-0039.1993.tb01982.x;
RA   Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J.,
RA   Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L.,
RA   du Toit E.D., Parham P.;
RT   "Structural diversity in the HLA-A10 family of alleles: correlations
RT   with serology.";
RL   Tissue Antigens 41:72-80(1993).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; TYR-344; SER-345;
RP   SER-349; SER-352; SER-356 AND SER-359, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-34 are known: A*34:01
CC       (Aw-34.1) and A*34:02 (Aw-34.2). The sequence shown is that of
CC       A*34:01. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61704; CAA43873.1; -; mRNA.
DR   EMBL; X61705; CAA43874.1; -; mRNA.
DR   PIR; I37477; I37477.
DR   PIR; I37483; I37483.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   ProteinModelPortal; P30453; -.
DR   SMR; P30453; 25-294.
DR   iPTMnet; P30453; -.
DR   SwissPalm; P30453; -.
DR   DMDM; 231368; -.
DR   MaxQB; P30453; -.
DR   PRIDE; P30453; -.
DR   Ensembl; ENST00000383605; ENSP00000373100; ENSG00000206505.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30453; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-34 alpha chain.
FT                                /FTId=PRO_0000018826.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT       3      3       I -> V (in allele A*34:02).
FT                                {ECO:0000269|PubMed:1431115,
FT                                ECO:0000269|PubMed:8475492}.
FT                                /FTId=VAR_004379.
FT   VARIANT      90     90       K -> N (in allele A*34:02).
FT                                {ECO:0000269|PubMed:1431115,
FT                                ECO:0000269|PubMed:8475492}.
FT                                /FTId=VAR_004380.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056288.
FT   VARIANT     121    121       R -> I (in allele A*34:02).
FT                                {ECO:0000269|PubMed:1431115,
FT                                ECO:0000269|PubMed:8475492}.
FT                                /FTId=VAR_004381.
FT   VARIANT     129    129       P -> S (in allele A*34:02).
FT                                {ECO:0000269|PubMed:1431115,
FT                                ECO:0000269|PubMed:8475492}.
FT                                /FTId=VAR_004382.
FT   VARIANT     138    138       Q -> R (in allele A*34:02).
FT                                {ECO:0000269|PubMed:1431115,
FT                                ECO:0000269|PubMed:8475492}.
FT                                /FTId=VAR_004383.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056289.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056290.
FT   VARIANT     180    180       W -> L (in allele A*34:02).
FT                                {ECO:0000269|PubMed:1431115,
FT                                ECO:0000269|PubMed:8475492}.
FT                                /FTId=VAR_004384.
FT   VARIANT     312    312       L -> I (in allele A*34:02).
FT                                {ECO:0000269|PubMed:1431115,
FT                                ECO:0000269|PubMed:8475492}.
FT                                /FTId=VAR_004385.
SQ   SEQUENCE   365 AA;  41055 MW;  063BF63E6E6E01F6 CRC64;
     MAIMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRK VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ
     RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG ILAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A66_HUMAN              Reviewed;         365 AA.
AC   P30457; P30458;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   20-JAN-2016, entry version 132.
DE   RecName: Full=HLA class I histocompatibility antigen, A-66 alpha chain;
DE   AltName: Full=Aw-66;
DE   AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain;
DE   AltName: Full=MHC class I antigen A*66;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*66:01 AND A*66:02).
RX   PubMed=1940790; DOI=10.1084/jem.174.5.1085;
RA   Madrigal J., Belich M.P., Benjamin R.J., Little A.-M.,
RA   Hildebrand W.H., Mann D.L., Parham P.;
RT   "Molecular definition of a polymorphic antigen (LA45) of free HLA-A
RT   and -B heavy chains found on the surfaces of activated B and T
RT   cells.";
RL   J. Exp. Med. 174:1085-1095(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*66:02).
RX   PubMed=2139695; DOI=10.1084/jem.171.5.1431;
RA   Schnabl E., Stockinger H., Majdic O., Gaugitsch H., Lindley I.J.D.,
RA   Maurer D., Hajek-Rosenmayr A., Knapp W.;
RT   "Activated human T lymphocytes express MHC class I heavy chains not
RT   associated with beta 2-microglobulin.";
RL   J. Exp. Med. 171:1431-1442(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-322 (ALLELE A*66:01).
RA   Hurley C.K., Bei M.;
RL   Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; TYR-344; SER-345;
RP   SER-349; SER-352; SER-356 AND SER-359, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-66 are known: A*66:01 and
CC       A*66:02 (Aw67). The sequence shown is that of A*66:01.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61711; CAA43880.1; -; mRNA.
DR   EMBL; X61712; CAA43881.1; -; mRNA.
DR   EMBL; X51745; CAA36034.1; -; mRNA.
DR   EMBL; U17571; AAA56781.1; -; mRNA.
DR   PIR; JL0135; JL0135.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   ProteinModelPortal; P30457; -.
DR   SMR; P30457; 25-294.
DR   iPTMnet; P30457; -.
DR   DMDM; 231372; -.
DR   PRIDE; P30457; -.
DR   Ensembl; ENST00000383605; ENSP00000373100; ENSG00000206505.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30457; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-66 alpha chain.
FT                                /FTId=PRO_0000018829.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      28     28       S -> W (in allele A*66:02).
FT                                {ECO:0000269|PubMed:1940790,
FT                                ECO:0000269|PubMed:2139695}.
FT                                /FTId=VAR_004386.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056300.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056301.
FT   VARIANT     114    114       D -> A (in allele A*66:02).
FT                                {ECO:0000269|PubMed:1940790,
FT                                ECO:0000269|PubMed:2139695}.
FT                                /FTId=VAR_004387.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056302.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                /FTId=VAR_056303.
FT   VARIANT     187    187       R -> E (in allele A*66:02; requires 2
FT                                nucleotide substitutions).
FT                                {ECO:0000269|PubMed:1940790,
FT                                ECO:0000269|PubMed:2139695}.
FT                                /FTId=VAR_004388.
SQ   SEQUENCE   365 AA;  41082 MW;  A3272DBE4008328D CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ
     RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW
     RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL
     TACKV
//
ID   1A68_HUMAN              Reviewed;         365 AA.
AC   P01891; O19673; O19695; O19794; O19795; O43907; O77938; O98010;
AC   P10315; P79505; Q9MYA5; Q9MYC4; Q9TQG7; Q9TQN5; Q9UIN2;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 4.
DT   17-FEB-2016, entry version 158.
DE   RecName: Full=HLA class I histocompatibility antigen, A-68 alpha chain;
DE   AltName: Full=Aw-68;
DE   AltName: Full=HLA class I histocompatibility antigen, A-28 alpha chain;
DE   AltName: Full=MHC class I antigen A*68;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*68:02).
RX   PubMed=3496393;
RA   Holmes N., Ennis P., Wan A.M., Denney D.W., Parham P.;
RT   "Multiple genetic mechanisms have contributed to the generation of the
RT   HLA-A2/A28 family of class I MHC molecules.";
RL   J. Immunol. 139:936-941(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*68:02).
RA   Domena J.D.;
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*68:03).
RX   PubMed=8881043; DOI=10.1007/s002510050172;
RA   Ellexson M., Lau M., Terasaki P., Hildebrand W.H.;
RT   "Molecular characterization of HLA-A*6803.";
RL   Immunogenetics 45:78-79(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*68:08).
RX   PubMed=10395114; DOI=10.1034/j.1399-0039.1999.530614.x;
RA   Cox S.T., Arguello J.R., Marsh S.G.E., Boham E., Lau M., Kwan P.L.,
RA   Madrigal J.A., Little A.-M.;
RT   "Sequence of HLA-A*6808.";
RL   Tissue Antigens 53:597-600(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*68:011).
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of HLA-A*68011.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*68:17).
RX   PubMed=10885567; DOI=10.1034/j.1399-0039.2000.550509.x;
RA   Ramon D., Scott I., Cox S.T., Pesoa S., Vullo C., Little A.-M.,
RA   Madrigal J.A.;
RT   "HLA-A*6817, identified in the Kolla Amerindians of north-west
RT   Argentina possesses a novel nucleotide substitution.";
RL   Tissue Antigens 55:453-454(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*68:06).
RA   Bei M., Hurley C.K.;
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*68:03).
RC   TISSUE=Blood;
RX   PubMed=9271640; DOI=10.1007/s002510050304;
RA   Vargas-Alarcon G., Martinez-Laso J., Gomez-Casado E., Perez-Blas M.,
RA   Granados J., Alegre R., Alvarez M., Zuniga J., Arnaiz-Villena A.;
RT   "Description of HLA-A*6803 and A*68N in Mazatecan Indians from
RT   Mexico.";
RL   Immunogenetics 46:446-447(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*68:03).
RC   TISSUE=Blood;
RA   Blasczyk R.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*68:02).
RA   Edson S.M., Hurley C.K.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*68:09 AND A*68:10).
RX   PubMed=10852390; DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-206 (ALLELE A*68:16).
RX   PubMed=10803837; DOI=10.1007/s002510050618;
RA   Gomez-Casado E., Martinez-Laso J., Gonzalez-Hevilla M., Longas J.,
RA   Rubio I., Silvera-Redondo C., Garcia-Gomez A., Lowy E.,
RA   Arnaiz-Villena A.;
RT   "A novel HLA-A*6816 allele possible generated by a point mutation in a
RT   Chilean from Punta Arenas (Magellan Strait).";
RL   Immunogenetics 51:257-260(2000).
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*68:07 AND A*68:17).
RX   PubMed=11260503; DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-297 (ALLELE A*68:01).
RX   PubMed=3877632;
RA   Holmes N., Parham P.;
RT   "Exon shuffling in vivo can generate novel HLA class I molecules.";
RL   EMBO J. 4:2849-2854(1985).
RN   [15]
RP   PROTEIN SEQUENCE OF 25-294 (A*68:01).
RX   PubMed=6179086; DOI=10.1073/pnas.79.12.3813;
RA   Lopez de Castro J.A., Strominger J.L., Strong D.M., Orr H.T.;
RT   "Structure of crossreactive human histocompatibility antigens HLA-A28
RT   and HLA-A2: possible implications for the generation of HLA
RT   polymorphism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:3813-3817(1982).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-352; SER-356
RP   AND SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*68:01).
RX   PubMed=1448153; DOI=10.1038/360364a0;
RA   Guo H.-C., Jardetzky T.S., Garrett T.P.J., Lane W.S., Strominger J.L.,
RA   Wiley D.C.;
RT   "Different length peptides bind to HLA-Aw68 similarly at their ends
RT   but bulge out in the middle.";
RL   Nature 360:364-366(1992).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*68:01).
RX   PubMed=1448154; DOI=10.1038/360367a0;
RA   Silver M.L., Guo H.-C., Strominger J.L., Wiley D.C.;
RT   "Atomic structure of a human MHC molecule presenting an influenza
RT   virus peptide.";
RL   Nature 360:367-369(1992).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 25-199 (A*68:01).
RX   PubMed=7862664; DOI=10.1073/pnas.92.4.1218;
RA   Collins E.J., Garboczi D.N., Karpusas M.N., Wiley D.C.;
RT   "The three-dimensional structure of a class I major histocompatibility
RT   complex molecule missing the alpha 3 domain of the heavy chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1218-1221(1995).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-68 are known: A*68:01
CC       (Aw68.1), A*68:02, A*68:03. A*68:04, A*68:05, A*68:06, A*68:07,
CC       A*68:08, A*68:09, A*68:10, A*68:16 and A*68:17. The sequence shown
CC       is that of A*68:01. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03861; AAA03602.1; -; mRNA.
DR   EMBL; X03070; CAB56605.1; -; Genomic_DNA.
DR   EMBL; X03071; CAB56606.1; -; Genomic_DNA.
DR   EMBL; U41057; AAB41292.1; -; mRNA.
DR   EMBL; AJ315642; CAC44382.1; -; Genomic_DNA.
DR   EMBL; AF144013; AAF74211.1; -; Genomic_DNA.
DR   EMBL; AJ245567; CAB59722.1; -; Genomic_DNA.
DR   EMBL; AH005127; AAB50567.1; -; Genomic_DNA.
DR   EMBL; U89946; AAB82079.1; -; Genomic_DNA.
DR   EMBL; U89947; AAB82080.1; -; Genomic_DNA.
DR   EMBL; AJ001274; CAA04647.1; -; mRNA.
DR   EMBL; AH006296; AAC25782.1; -; Genomic_DNA.
DR   EMBL; AH007538; AAD22270.1; -; Genomic_DNA.
DR   EMBL; AH007605; AAD27539.1; -; Genomic_DNA.
DR   EMBL; AJ223972; CAA11708.1; -; Genomic_DNA.
DR   EMBL; AH007201; AAD02208.1; -; Genomic_DNA.
DR   EMBL; AH009406; AAF73477.1; -; Genomic_DNA.
DR   PIR; A02187; HLHU28.
DR   PIR; A24671; HLHUAW.
DR   PIR; I38441; I38441.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   PDB; 1HSB; X-ray; 1.90 A; A=25-294.
DR   PDB; 1TMC; X-ray; 2.30 A; A=25-199.
DR   PDB; 2HLA; X-ray; 2.60 A; A=25-294.
DR   PDB; 4HWZ; X-ray; 2.40 A; A=25-298.
DR   PDB; 4HX1; X-ray; 1.80 A; A=25-296.
DR   PDB; 4I48; X-ray; 2.80 A; A=25-296.
DR   PDBsum; 1HSB; -.
DR   PDBsum; 1TMC; -.
DR   PDBsum; 2HLA; -.
DR   PDBsum; 4HWZ; -.
DR   PDBsum; 4HX1; -.
DR   PDBsum; 4I48; -.
DR   ProteinModelPortal; P01891; -.
DR   SMR; P01891; 25-294.
DR   IntAct; P01891; 5.
DR   MINT; MINT-274751; -.
DR   iPTMnet; P01891; -.
DR   DMDM; 13124681; -.
DR   MaxQB; P01891; -.
DR   PRIDE; P01891; -.
DR   Ensembl; ENST00000457879; ENSP00000403575; ENSG00000235657.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P01891; -.
DR   HOVERGEN; HBG016709; -.
DR   InParanoid; P01891; -.
DR   PhylomeDB; P01891; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   EvolutionaryTrace; P01891; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; IMP:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; IMP:UniProtKB.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0019882; P:antigen processing and presentation; IBA:GO_Central.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Host-virus interaction; Immunity;
KW   Membrane; MHC I; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24       {ECO:0000269|PubMed:6179086}.
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-68 alpha chain.
FT                                /FTId=PRO_0000018830.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      36     36       V -> M (in allele A*68:02).
FT                                {ECO:0000269|PubMed:3496393,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.2}.
FT                                /FTId=VAR_004389.
FT   VARIANT      86     87       RN -> EE (in allele A*68:10).
FT                                {ECO:0000269|PubMed:10852390}.
FT                                /FTId=VAR_010362.
FT   VARIANT      89     89       R -> G (in dbSNP:rs1059459).
FT                                /FTId=VAR_056304.
FT   VARIANT      94     94       Q -> H (in allele A*68:03, allele A*68:04
FT                                and allele A*68:05; dbSNP:rs1059463).
FT                                {ECO:0000269|PubMed:8881043,
FT                                ECO:0000269|PubMed:9271640,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_010363.
FT   VARIANT      97     97       T -> I (in allele A*68:04).
FT                                /FTId=VAR_010364.
FT   VARIANT      98     98       D -> H (in allele A*68:05).
FT                                /FTId=VAR_010365.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_056305.
FT   VARIANT     121    121       M -> R (in allele A*68:02).
FT                                {ECO:0000269|PubMed:3496393,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.2}.
FT                                /FTId=VAR_004390.
FT   VARIANT     129    129       S -> P (in allele A*68:02;
FT                                dbSNP:rs1136700).
FT                                {ECO:0000269|PubMed:3496393,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.2}.
FT                                /FTId=VAR_004391.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056306.
FT   VARIANT     138    138       R -> E (in allele A*68:06; requires 2
FT                                nucleotide substitutions).
FT                                {ECO:0000269|PubMed:10852390}.
FT                                /FTId=VAR_010366.
FT   VARIANT     138    138       R -> H (in allele A*68:02).
FT                                {ECO:0000269|PubMed:3496393,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.2}.
FT                                /FTId=VAR_004392.
FT   VARIANT     140    140       D -> H (in allele A*68:06 and allele
FT                                A*68:07). {ECO:0000269|PubMed:10885567}.
FT                                /FTId=VAR_010367.
FT   VARIANT     140    140       D -> V (in allele A*68:17).
FT                                {ECO:0000269|PubMed:10885567,
FT                                ECO:0000269|PubMed:11260503}.
FT                                /FTId=VAR_010368.
FT   VARIANT     140    140       D -> Y (in allele A*68:02).
FT                                {ECO:0000269|PubMed:3496393,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.2}.
FT                                /FTId=VAR_004393.
FT   VARIANT     175    175       H -> L (in allele A*68:16).
FT                                {ECO:0000269|PubMed:10803837}.
FT                                /FTId=VAR_010369.
FT   VARIANT     180    180       W -> L (in allele A*68:08).
FT                                {ECO:0000269|PubMed:10395114}.
FT                                /FTId=VAR_010370.
FT   VARIANT     180    180       W -> Q (in allele A*68:09; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_010371.
FT   CONFLICT    206    206       T -> A (in Ref. 12; AAF74211).
FT                                {ECO:0000305}.
FT   CONFLICT    231    231       S -> G (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       27     36       {ECO:0000244|PDB:4HX1}.
FT   STRAND       41     43       {ECO:0000244|PDB:4HX1}.
FT   STRAND       45     52       {ECO:0000244|PDB:4HX1}.
FT   STRAND       55     61       {ECO:0000244|PDB:4HX1}.
FT   STRAND       64     66       {ECO:0000244|PDB:4HX1}.
FT   HELIX        74     76       {ECO:0000244|PDB:4HX1}.
FT   HELIX        81    108       {ECO:0000244|PDB:4HX1}.
FT   STRAND      113    115       {ECO:0000244|PDB:1TMC}.
FT   STRAND      118    127       {ECO:0000244|PDB:4HX1}.
FT   STRAND      133    142       {ECO:0000244|PDB:4HX1}.
FT   STRAND      145    150       {ECO:0000244|PDB:4HX1}.
FT   STRAND      154    161       {ECO:0000244|PDB:4HX1}.
FT   HELIX       162    173       {ECO:0000244|PDB:4HX1}.
FT   HELIX       176    185       {ECO:0000244|PDB:4HX1}.
FT   HELIX       187    198       {ECO:0000244|PDB:4HX1}.
FT   HELIX       200    203       {ECO:0000244|PDB:4HX1}.
FT   STRAND      210    217       {ECO:0000244|PDB:4HX1}.
FT   STRAND      219    235       {ECO:0000244|PDB:4HX1}.
FT   STRAND      238    243       {ECO:0000244|PDB:4HX1}.
FT   STRAND      246    248       {ECO:0000244|PDB:4HX1}.
FT   STRAND      252    254       {ECO:0000244|PDB:4HX1}.
FT   STRAND      261    263       {ECO:0000244|PDB:4HX1}.
FT   STRAND      265    274       {ECO:0000244|PDB:4HX1}.
FT   HELIX       278    280       {ECO:0000244|PDB:4HX1}.
FT   STRAND      281    286       {ECO:0000244|PDB:4HX1}.
FT   STRAND      290    292       {ECO:0000244|PDB:1HSB}.
FT   STRAND      294    296       {ECO:0000244|PDB:4HX1}.
SQ   SEQUENCE   365 AA;  40909 MW;  78539C59DB8B1DFC CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     MMYGCDVGSD GRFLRGYRQD AYDGKDYIAL KEDLRSWTAA DMAAQTTKHK WEAAHVAEQW
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWVA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1A80_HUMAN              Reviewed;         365 AA.
AC   Q09160;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   20-JAN-2016, entry version 124.
DE   RecName: Full=HLA class I histocompatibility antigen, A-80 alpha chain;
DE   AltName: Full=Aw-80;
DE   AltName: Full=HLA class I histocompatibility antigen, A-1 alpha chain;
DE   AltName: Full=MHC class I antigen A*80;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*80:01).
RX   PubMed=8188325; DOI=10.1007/BF00176169;
RA   Balas A., Garcia-Sanchez F., Gomez-Reino F., Vicario J.L.;
RT   "Characterization of a new and highly distinguishable HLA-A allele in
RT   a Spanish family.";
RL   Immunogenetics 39:452-452(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*80:01).
RX   PubMed=8284791; DOI=10.1111/j.1399-0039.1993.tb02186.x;
RA   Domena J.D., Hildebrand W.H., Bias W.B., Parham P.;
RT   "A sixth family of HLA-A alleles defined by HLA-A*8001.";
RL   Tissue Antigens 42:156-159(1993).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-352; SER-356
RP   AND SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-166, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The only allele of A-80 known is A*80:01 which is
CC       shown here. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03754; AAC04322.1; -; mRNA.
DR   EMBL; L18898; AAA17012.1; -; mRNA.
DR   PIR; I59638; I38439.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   ProteinModelPortal; Q09160; -.
DR   SMR; Q09160; 25-298.
DR   MINT; MINT-4655865; -.
DR   iPTMnet; Q09160; -.
DR   DMDM; 1168212; -.
DR   PRIDE; Q09160; -.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_Q09160; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-80 alpha chain.
FT                                /FTId=PRO_0000018832.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT     121    121       I -> M (in dbSNP:rs1136695).
FT                                /FTId=VAR_056313.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_056314.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056315.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056316.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056317.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                {ECO:0000244|PubMed:21269460}.
FT                                /FTId=VAR_056318.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_056319.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056320.
SQ   SEQUENCE   365 AA;  40792 MW;  CE1BC1CD60CA8FA8 CRC64;
     MAVMPPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDSQFVQF
     DSDAASQRME PRAPWIEQEE PEYWDEETRN VKAHSQTNRA NLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAARRAEQL
     RAYLEGECVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGKEKR YTCHVQHEGL PEPLTLRWEP
     SSQPTIPIVG IIAGLVLLGA VIAGAVVAAV MWRKKSSVRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
ID   1B01_GORGO              Reviewed;         362 AA.
AC   P30379;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   14-OCT-2015, entry version 79.
DE   RecName: Full=Class I histocompatibility antigen, Gogo-B*0101 alpha chain;
DE   Flags: Precursor;
OS   Gorilla gorilla gorilla (Western lowland gorilla).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Gorilla.
OX   NCBI_TaxID=9595;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1744581; DOI=10.1084/jem.174.6.1491;
RA   Lawlor D.A., Warren E., Taylor P., Parham P.;
RT   "Gorilla class I major histocompatibility complex alleles: comparison
RT   to human and chimpanzee class I.";
RL   J. Exp. Med. 174:1491-1509(1991).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60255; CAA42807.1; -; mRNA.
DR   PIR; JH0539; JH0539.
DR   ProteinModelPortal; P30379; -.
DR   SMR; P30379; 25-300.
DR   PRIDE; P30379; -.
DR   HOVERGEN; HBG016709; -.
DR   Proteomes; UP000001519; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; IEA:InterPro.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Immunity; Membrane;
KW   MHC I; Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    362       Class I histocompatibility antigen, Gogo-
FT                                B*0101 alpha chain.
FT                                /FTId=PRO_0000018901.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
SQ   SEQUENCE   362 AA;  40171 MW;  419EEE29817165A4 CRC64;
     MRVTAPRTLL LLLSAALALT ETWAGSHSMR YFDTAVSRPG RGEPRFITVG YVDDTQFVRF
     DSDAASPRME PRAPWIEQEG PEYWDRETQT SKAQAQTDRE NLRIALRYYN QSEAGSHTIQ
     RMFGCDVGPD GRLLRGYSQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGTCVE WLRRYLENGR ETLQRADTPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEER YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVTAV ICRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B02_GORGO              Reviewed;         362 AA.
AC   P30380;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   14-OCT-2015, entry version 79.
DE   RecName: Full=Class I histocompatibility antigen, Gogo-B*0102 alpha chain;
DE   Flags: Precursor;
OS   Gorilla gorilla gorilla (Western lowland gorilla).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Gorilla.
OX   NCBI_TaxID=9595;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1744581; DOI=10.1084/jem.174.6.1491;
RA   Lawlor D.A., Warren E., Taylor P., Parham P.;
RT   "Gorilla class I major histocompatibility complex alleles: comparison
RT   to human and chimpanzee class I.";
RL   J. Exp. Med. 174:1491-1509(1991).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60693; CAA43101.1; -; mRNA.
DR   PIR; JH0540; JH0540.
DR   ProteinModelPortal; P30380; -.
DR   SMR; P30380; 25-300.
DR   HOVERGEN; HBG016709; -.
DR   Proteomes; UP000001519; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; IEA:InterPro.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Immunity; Membrane;
KW   MHC I; Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    362       Class I histocompatibility antigen, Gogo-
FT                                B*0102 alpha chain.
FT                                /FTId=PRO_0000018902.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
SQ   SEQUENCE   362 AA;  40205 MW;  E19EEE2B7CC7BECD CRC64;
     MRVTAPRTLL LLLSAALALT ETWAGSHSMR YFDTAVSRPG RGEPRFITVG YVDDTQFVRF
     DSDAASPRME PRAPWIEQEG PEYWDRETQT SKAQAQTDRE NLRIALRYYN QSEAGSHTFQ
     RMFGCDVGPD GRLLRGYSQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGTCVE WLRRYLENGR ETLQRADTPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEER YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVTAV ICRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B13_HUMAN              Reviewed;         362 AA.
AC   P30461; O02956; O78180; Q29661; Q29933; Q9GIY5;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   09-DEC-2015, entry version 131.
DE   RecName: Full=HLA class I histocompatibility antigen, B-13 alpha chain;
DE   AltName: Full=MHC class I antigen B*13;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*13:02).
RX   PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*13:02).
RX   PubMed=3257938; DOI=10.1007/BF00376123;
RA   Zemmour J., Ennis P.D., Parham P., Dupont B.;
RT   "Comparison of the structure of HLA-Bw47 to HLA-B13 and its
RT   relationship to 21-hydroxylase deficiency.";
RL   Immunogenetics 27:281-287(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*13:01).
RX   PubMed=2914710; DOI=10.1007/BF00395860;
RA   Kato K., Dupont B., Yang S.Y.;
RT   "Localization of nucleotide sequence which determines Mongoloid
RT   subtype of HLA-B13.";
RL   Immunogenetics 29:117-120(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*13:01 AND B*13:02).
RC   TISSUE=Blood;
RX   PubMed=7558929; DOI=10.1016/0198-8859(94)00120-F;
RA   Lin L., Tokunaga K., Nakajima F., Ishikawa Y., Kashiwase K.,
RA   Tanaka H., Kuwata S., Sideltseva E., Akaza T., Tadokoro K.,
RA   Shibata Y., Chandanayingyong D., Juji T.;
RT   "Both HLA-B*1301 and B*1302 exist in Asian populations and are
RT   associated with different haplotypes.";
RL   Hum. Immunol. 43:51-56(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*13:03).
RC   TISSUE=Blood;
RX   PubMed=8655357; DOI=10.1016/0198-8859(95)00143-3;
RA   Balas A., Garcia-Sanchez F., Vicario J.L.;
RT   "HLA-B*1303: a new example of poor correlation between serology and
RT   structure.";
RL   Hum. Immunol. 45:32-36(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*13:04).
RX   PubMed=9328792; DOI=10.1016/S0198-8859(97)00055-4;
RA   Ellexson M., Lai-Kwan P., Lau M., Muto K., Terasaki P., Cole J.,
RA   Thompson C., Hildebrand W.H.;
RT   "Polymorphism at codons 114, 116, 145, and 163 muddle the typing of
RT   HLA-B1304.";
RL   Hum. Immunol. 55:66-73(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*13:08).
RA   Carter V., Dunn P.P.;
RT   "Identification of a HLA-B*13 null allele.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-169, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-13 are known: B*13:01
CC       (B13.1), B*13:02 (B13.2), B*13:04 and B*13:08. The sequence shown
CC       is that of B*13:02.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24041; AAA59660.1; -; Genomic_DNA.
DR   EMBL; M19757; AAA52657.1; -; Genomic_DNA.
DR   EMBL; M24075; AAA59627.1; -; Genomic_DNA.
DR   EMBL; D50290; BAA08821.1; -; mRNA.
DR   EMBL; D50291; BAA08822.1; -; mRNA.
DR   EMBL; U14943; AAB06829.1; -; mRNA.
DR   EMBL; U75533; AAC31793.1; -; mRNA.
DR   EMBL; AJ295279; CAC17137.1; -; Genomic_DNA.
DR   PIR; A45850; A45850.
DR   PIR; I54442; I54442.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30461; -.
DR   SMR; P30461; 25-300.
DR   IntAct; P30461; 1.
DR   MINT; MINT-1195012; -.
DR   DMDM; 231382; -.
DR   PRIDE; P30461; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; HLA-B; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MalaCards; HLA-B; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30461; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-B; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-B; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042605; F:peptide antigen binding; IDA:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-13 alpha chain.
FT                                /FTId=PRO_0000018835.
FT   TOPO_DOM     25    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT     118    119       TW -> II (in allele B*13:01).
FT                                /FTId=VAR_016357.
FT   VARIANT     121    121       T -> R (in allele B*13:01).
FT                                /FTId=VAR_016358.
FT   VARIANT     138    138       N -> D (in allele B*13:04).
FT                                /FTId=VAR_016360.
FT   VARIANT     140    140       L -> S (in allele B*13:04).
FT                                /FTId=VAR_016361.
FT   VARIANT     169    169       L -> R (in allele B*13:03 and allele
FT                                B*13:04; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000244|PubMed:25944712}.
FT                                /FTId=VAR_016362.
FT   VARIANT     183    183       Y -> C (in allele B*13:08).
FT                                /FTId=VAR_016359.
FT   VARIANT     187    187       E -> L (in allele B*13:03 and allele
FT                                B*13:04; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016363.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056330.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056331.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061397.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061398.
SQ   SEQUENCE   362 AA;  40474 MW;  28FF66B20961C75C CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFITVG YVDDTQFVRF
     DSDATSPRMA PRAPWIEQEG PEYWDRETQI SKTNTQTYRE NLRTALRYYN QSEAGSHTWQ
     TMYGCDLGPD GRLLRGHNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQLK WEAARVAEQL
     RAYLEGECVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B18_HUMAN              Reviewed;         362 AA.
AC   P30466; O62897; Q29845; Q5JP37; Q9BCM6; Q9GJ23; Q9MY84; Q9MYC7;
AC   Q9TP37; Q9TQH7;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   17-FEB-2016, entry version 138.
DE   RecName: Full=HLA class I histocompatibility antigen, B-18 alpha chain;
DE   AltName: Full=MHC class I antigen B*18;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*18:01).
RX   PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*18:02).
RC   TISSUE=Blood;
RX   PubMed=7751157; DOI=10.1016/0198-8859(94)00073-Y;
RA   Lin L., Tokunaga K., Ishikawa Y., Kashiwase K., Nakajima F.,
RA   Nishimura M., Kuwata S., Akaza T., Tadokoro K., Shibata Y., Juji T.;
RT   "A new B18 sequence (B*1802) from Asian individuals.";
RL   Hum. Immunol. 42:23-26(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*18:01).
RC   TISSUE=Blood;
RX   PubMed=12622774; DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*18:03).
RA   Dunn P.P.J.;
RT   "Complete nucleotide sequencing of HLA class I genes.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*18:07).
RA   Kennedy C.T., Dodd R., Le T., Wallace R., Ng G., Hersee J.,
RA   Taverniti A., Kennedy A., Moses J., Trejaut J., Dunckley H.;
RT   "HLA-B typing with sequence specific oligonucleotides reveals a new
RT   allele, B*MF.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES B*18:07; B*18:10;
RP   B*18:11; B*18:12 AND B*18:13).
RX   PubMed=11556976; DOI=10.1034/j.1399-0039.2001.057005481.x;
RA   Steiner N.K., Kosman C., Jones P.F., Gans C.P., Rodriguez-Marino S.G.,
RA   Rizzuto G., Baldassarre L.A., Edson S., Koester R., Sese D.,
RA   Mitton W., Ng J., Hartzman R.J., Hurley C.K.;
RT   "Twenty-nine new HLA-B alleles associated with antigens in the 5C
RT   CREG.";
RL   Tissue Antigens 57:481-485(2001).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-87, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-18 are known: B*18:01
CC       B*18:02, B*18:03, B*18:07 (B*MF), B*18:10, B*18:11, B*18:12 and
CC       B*18:13. The sequence shown is that of B*18:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24039; AAA59662.1; -; Genomic_DNA.
DR   EMBL; D25275; BAA04965.1; -; mRNA.
DR   EMBL; AJ310507; CAC34572.1; -; Genomic_DNA.
DR   EMBL; AJ309979; CAC34305.1; -; Genomic_DNA.
DR   EMBL; AL845443; CAI41903.1; -; Genomic_DNA.
DR   EMBL; AH007328; AAD13298.1; -; Genomic_DNA.
DR   EMBL; AF054010; AAC32821.1; -; Genomic_DNA.
DR   EMBL; AF054009; AAC32821.1; JOINED; Genomic_DNA.
DR   EMBL; AH008878; AAF20813.1; -; Genomic_DNA.
DR   EMBL; AH009390; AAF73066.1; -; Genomic_DNA.
DR   EMBL; AH009624; AAF85974.1; -; Genomic_DNA.
DR   EMBL; AF310139; AAG27466.1; -; Genomic_DNA.
DR   EMBL; AF310138; AAG27466.1; JOINED; Genomic_DNA.
DR   PIR; I61860; I61860.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 4JQV; X-ray; 1.50 A; A=25-302.
DR   PDB; 4XXC; X-ray; 1.43 A; A=25-303.
DR   PDBsum; 4JQV; -.
DR   PDBsum; 4XXC; -.
DR   ProteinModelPortal; P30466; -.
DR   SMR; P30466; 25-300.
DR   BioGrid; 109351; 70.
DR   iPTMnet; P30466; -.
DR   SwissPalm; P30466; -.
DR   DMDM; 231388; -.
DR   MaxQB; P30466; -.
DR   PRIDE; P30466; -.
DR   Ensembl; ENST00000359635; ENSP00000352656; ENSG00000206450.
DR   UCSC; uc011imy.2; human.
DR   GeneCards; HLA-B; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MalaCards; HLA-B; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30466; -.
DR   HOVERGEN; HBG016709; -.
DR   OMA; HAQNHRV; -.
DR   PhylomeDB; P30466; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-B; human.
DR   GenomeRNAi; 3106; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-B; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-18 alpha chain.
FT                                /FTId=PRO_0000018838.
FT   TOPO_DOM     25    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      87     87       N -> E (in allele B*18:12; requires 2
FT                                nucleotide substitutions).
FT                                {ECO:0000244|PubMed:24275569}.
FT                                /FTId=VAR_016661.
FT   VARIANT      91     91       S -> F (in allele B*18:07).
FT                                /FTId=VAR_016662.
FT   VARIANT      98     98       Y -> D (in allele B*18:03).
FT                                /FTId=VAR_016377.
FT   VARIANT     121    121       R -> N (in allele B*18:02; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016378.
FT   VARIANT     180    180       L -> R (in allele B*18:13).
FT                                /FTId=VAR_016663.
FT   VARIANT     187    187       T -> E (in allele B*18:10; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_016664.
FT   VARIANT     195    195       H -> Y (in allele B*18:10 and allele
FT                                B*18:11).
FT                                /FTId=VAR_016665.
FT   STRAND       27     36       {ECO:0000244|PDB:4XXC}.
FT   STRAND       45     52       {ECO:0000244|PDB:4XXC}.
FT   STRAND       55     61       {ECO:0000244|PDB:4XXC}.
FT   STRAND       64     66       {ECO:0000244|PDB:4XXC}.
FT   HELIX        74     76       {ECO:0000244|PDB:4XXC}.
FT   HELIX        81    108       {ECO:0000244|PDB:4XXC}.
FT   STRAND      118    127       {ECO:0000244|PDB:4XXC}.
FT   STRAND      133    142       {ECO:0000244|PDB:4XXC}.
FT   STRAND      145    150       {ECO:0000244|PDB:4XXC}.
FT   STRAND      157    161       {ECO:0000244|PDB:4XXC}.
FT   HELIX       162    173       {ECO:0000244|PDB:4XXC}.
FT   HELIX       176    185       {ECO:0000244|PDB:4XXC}.
FT   HELIX       187    198       {ECO:0000244|PDB:4XXC}.
FT   HELIX       200    203       {ECO:0000244|PDB:4XXC}.
FT   STRAND      210    235       {ECO:0000244|PDB:4XXC}.
FT   STRAND      238    243       {ECO:0000244|PDB:4XXC}.
FT   TURN        249    251       {ECO:0000244|PDB:4XXC}.
FT   STRAND      261    263       {ECO:0000244|PDB:4XXC}.
FT   STRAND      265    274       {ECO:0000244|PDB:4XXC}.
FT   HELIX       278    280       {ECO:0000244|PDB:4XXC}.
FT   STRAND      281    286       {ECO:0000244|PDB:4XXC}.
FT   STRAND      290    292       {ECO:0000244|PDB:4JQV}.
FT   STRAND      294    296       {ECO:0000244|PDB:4XXC}.
SQ   SEQUENCE   362 AA;  40275 MW;  106552F4A0F28E17 CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFHTSVSRPG RGEPRFISVG YVDGTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRNTQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGTCVE WLRRHLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B27_HUMAN              Reviewed;         362 AA.
AC   P03989; O19692; P10317; P10318; P19373; P30467; Q08136; Q29693;
AC   Q29846; Q29961;
DT   23-OCT-1986, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 2.
DT   17-FEB-2016, entry version 166.
DE   RecName: Full=HLA class I histocompatibility antigen, B-27 alpha chain;
DE   AltName: Full=MHC class I antigen B*27;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*27:01).
RX   PubMed=3912316;
RA   Weiss E.H., Kuon W., Doerner C., Lang M., Riethmueller G.;
RT   "Organization, sequence and expression of the HLA-B27 gene: a
RT   molecular approach to analyze HLA and disease associations.";
RL   Immunobiology 170:367-380(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-361 (ALLELE B*27:01).
RX   PubMed=3485286; DOI=10.1073/pnas.83.5.1428;
RA   Szoets H., Riethmueller G., Weiss E., Meo T.;
RT   "Complete sequence of HLA-B27 cDNA identified through the
RT   characterization of structural markers unique to the HLA-A, -B, and -C
RT   allelic series.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1428-1432(1986).
RN   [3]
RP   PROTEIN SEQUENCE OF 25-295 (B*27:01).
RX   PubMed=2408663; DOI=10.1021/bi00328a025;
RA   Ezquerra A., Bragado R., Vega M.A., Strominger J.L., Woody J.,
RA   Lopez de Castro J.A.;
RT   "Primary structure of papain-solubilized human histocompatibility
RT   antigen HLA-B27.";
RL   Biochemistry 24:1733-1741(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES B*27:01 AND B*27:02).
RX   PubMed=3011411;
RA   Seemann G.H.A., Rein R.S., Brown C.S., Ploegh H.L.;
RT   "Gene conversion-like mechanisms may generate polymorphism in human
RT   class I genes.";
RL   EMBO J. 5:547-552(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:02).
RX   PubMed=7482496; DOI=10.1111/j.1399-0039.1995.tb02475.x;
RA   Moses J.H., Marsh S.G.E., Arnett K.L., Adams E.J., Bodmer J.G.,
RA   Parham P.;
RT   "On the nucleotide sequences of B*2702 and B*2705.";
RL   Tissue Antigens 46:50-53(1995).
RN   [6]
RP   PROTEIN SEQUENCE OF 86-107 AND 171-181 (B*27:02).
RX   PubMed=2414775; DOI=10.1073/pnas.82.21.7394;
RA   Vega M.A., Ezquerra A., Rojo S., Aparicio P., Bragado R.,
RA   Lopez de Castro J.A.;
RT   "Structural analysis of an HLA-B27 functional variant: identification
RT   of residues that contribute to the specificity of recognition by
RT   cytolytic T lymphocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:7394-7398(1985).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*27:03).
RX   PubMed=3286582; DOI=10.1016/0198-8859(88)90072-9;
RA   Choo S.Y., St John T., Orr H.T., Hansen J.A.;
RT   "Molecular analysis of the variant alloantigen HLA-B27d (HLA-B*2703)
RT   identifies a unique single amino acid substitution.";
RL   Hum. Immunol. 21:209-219(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES B*27:04 AND B*27:06).
RX   PubMed=8550101; DOI=10.1007/BF00176678;
RA   Rudwaleit M., Bowness P., Wordsworth P.;
RT   "The nucleotide sequence of HLA-B*2704 reveals a new amino acid
RT   substitution in exon 4 which is also present in HLA-B*2706.";
RL   Immunogenetics 43:160-162(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-298 (ALLELE B*27:05).
RX   PubMed=3489755;
RA   Coppin H.L., McDevitt H.O.;
RT   "Absence of polymorphism between HLA-B27 genomic exon sequences
RT   isolated from normal donors and ankylosing spondylitis patients.";
RL   J. Immunol. 137:2168-2172(1986).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:06).
RX   PubMed=8276469; DOI=10.1007/BF00241265;
RA   Vilches C., de Pablo R., Kreisler M.;
RT   "Nucleotide sequence of HLA-B*2706.";
RL   Immunogenetics 39:219-219(1994).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:07).
RX   PubMed=1711072;
RA   Choo Y.S., Fan L.A., Hansen J.A.;
RT   "A novel HLA-B27 allele maps B27 allospecificity to the region around
RT   position 70 in the alpha 1 domain.";
RL   J. Immunol. 147:174-180(1991).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:08).
RX   PubMed=7974468; DOI=10.1111/j.1399-0039.1994.tb02356.x;
RA   Hildebrand W.H., Domena J.D., Shen S.Y., Marsh S.G.E., Bunce M.,
RA   Guttridge M.G., Darke C., Parham P.;
RT   "The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27
RT   (B*2708).";
RL   Tissue Antigens 44:47-51(1994).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*27:09).
RC   TISSUE=Blood;
RX   PubMed=8089488;
RA   Del Porto P., D'Amato M., Fiorillo M.T., Tuosto L., Piccolella E.,
RA   Sorrentino R.;
RT   "Identification of a novel HLA-B27 subtype by restriction analysis of
RT   a cytotoxic gamma/delta T cell clone.";
RL   J. Immunol. 153:3093-3100(1994).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-300.
RX   PubMed=1525820; DOI=10.1016/0092-8674(92)90252-8;
RA   Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C.;
RT   "The three-dimensional structure of HLA-B27 at 2.1-A resolution
RT   suggests a general mechanism for tight peptide binding to MHC.";
RL   Cell 70:1035-1048(1992).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-300.
RX   PubMed=1922337; DOI=10.1038/353321a0;
RA   Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C.;
RT   "The structure of HLA-B27 reveals nonamer self-peptides bound in an
RT   extended conformation.";
RL   Nature 353:321-325(1991).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-300.
RX   PubMed=12244049; DOI=10.1074/jbc.M206392200;
RA   Hulsmeyer M., Hillig R.C., Volz A., Ruhl M., Schroder W., Saenger W.,
RA   Ziegler A., Uchanska-Ziegler B.;
RT   "HLA-B27 subtypes differentially associated with disease exhibit
RT   subtle structural alterations.";
RL   J. Biol. Chem. 277:47844-47853(2002).
RN   [20]
RP   3D-STRUCTURE MODELING OF 115-206.
RX   PubMed=7846047; DOI=10.1073/pnas.92.3.753;
RA   Rognan D., Scapozza L., Folkers G., Daser A.;
RT   "Rational design of nonnatural peptides as high-affinity ligands for
RT   the HLA-B*2705 human leukocyte antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:753-757(1995).
RN   [21]
RP   DISEASE, AND POSSIBLE PROTECTIVE ROLE OF ALLELE B*27:07.
RX   PubMed=15603872; DOI=10.1016/j.humimm.2004.08.177;
RA   Varnavidou-Nicolaidou A., Karpasitou K., Georgiou D., Stylianou G.,
RA   Kokkofitou A., Michalis C., Constantina C., Gregoriadou C.,
RA   Kyriakides G.;
RT   "HLA-B27 in the Greek Cypriot population: distribution of subtypes in
RT   patients with ankylosing spondylitis and other HLA-B27-related
RT   diseases. The possible protective role of B*2707.";
RL   Hum. Immunol. 65:1451-1454(2004).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-65, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-27 are known:
CC       B*27:01=B*27:05, B*27:02 (B27.2; B-27k; B27e), B*27:03 (B27d),
CC       B*27:04, B*27:06, B*27:07, B*27:08 (B7Qui) and B*27:09 (B27-ci).
CC       The sequence shown is that of B*27:01.
CC   -!- DISEASE: Spondyloarthropathy 1 (SPDA1) [MIM:106300]: A chronic
CC       rheumatic disease with multifactorial inheritance. It includes a
CC       spectrum of related disorders comprising ankylosing spondylitis, a
CC       subset of psoriatic arthritis, reactive arthritis (e.g. Reiter
CC       syndrome), arthritis associated with inflammatory bowel disease
CC       and undifferentiated spondyloarthropathy. These disorders may
CC       occur simultaneously or sequentially in the same patient, probably
CC       representing various phenotypic expressions of the same disease.
CC       Ankylosing spondylitis is the form of rheumatoid arthritis
CC       affecting the spine and is considered the prototype of
CC       seronegative spondyloarthropathies. It produces pain and stiffness
CC       as a result of inflammation of the sacroiliac, intervertebral, and
CC       costovertebral joints. Note=Disease susceptibility is associated
CC       with variations affecting the gene represented in this entry. A
CC       restricted number of HLA-B27 subtypes can be associated with
CC       ankylosing spondylitis and other B27-related diseases, and an
CC       elevated frequency of the B*2702 allele in ankylosing spondylitis
CC       patients is identified. The allele B*2707 seems to have a
CC       protective role some populations because it was found only in the
CC       healthy controls.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03945; CAA27578.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X03664; CAA27301.1; -; Genomic_DNA.
DR   EMBL; X03667; CAA27301.1; JOINED; Genomic_DNA.
DR   EMBL; L38504; AAA69724.1; -; mRNA.
DR   EMBL; M54883; AAA59616.1; -; Genomic_DNA.
DR   EMBL; X03665; CAA27302.1; -; Genomic_DNA.
DR   EMBL; X03666; CAA27302.1; JOINED; Genomic_DNA.
DR   EMBL; M12967; AAA36221.1; -; Genomic_DNA.
DR   EMBL; U27608; AAC50444.1; -; mRNA.
DR   EMBL; U35734; AAC50447.1; -; mRNA.
DR   EMBL; M14013; AAA59643.1; -; Genomic_DNA.
DR   EMBL; X73578; CAA51980.1; -; mRNA.
DR   EMBL; M62852; AAA59647.1; -; mRNA.
DR   EMBL; L19923; AAA59658.1; -; mRNA.
DR   EMBL; Z33453; CAA83876.1; -; mRNA.
DR   PIR; I37515; I37515.
DR   PIR; I56116; I56116.
DR   PIR; S07441; HLHUB2.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 1HSA; X-ray; 2.10 A; A/D=25-300.
DR   PDB; 1JGD; X-ray; 1.90 A; A=25-300.
DR   PDB; 1JGE; X-ray; 2.10 A; A=25-300.
DR   PDB; 1K5N; X-ray; 1.09 A; A=25-300.
DR   PDB; 1OF2; X-ray; 2.20 A; A=25-300.
DR   PDB; 1OGT; X-ray; 1.47 A; A=25-300.
DR   PDB; 1ROG; Model; -; A=25-206.
DR   PDB; 1ROH; Model; -; A=25-206.
DR   PDB; 1ROI; Model; -; A=25-206.
DR   PDB; 1ROJ; Model; -; A=25-206.
DR   PDB; 1ROK; Model; -; A=25-206.
DR   PDB; 1ROL; Model; -; A=25-206.
DR   PDB; 1UXS; X-ray; 1.55 A; A=25-300.
DR   PDB; 1UXW; X-ray; 1.71 A; A=25-300.
DR   PDB; 1W0V; X-ray; 2.27 A; A=25-300.
DR   PDB; 1W0W; X-ray; 2.10 A; A=25-300.
DR   PDB; 2A83; X-ray; 1.40 A; A=25-300.
DR   PDB; 2BSR; X-ray; 2.30 A; A=25-300.
DR   PDB; 2BSS; X-ray; 2.00 A; A=25-300.
DR   PDB; 2BST; X-ray; 2.10 A; A=25-300.
DR   PDB; 3B3I; X-ray; 1.86 A; A=25-300.
DR   PDB; 3B6S; X-ray; 1.80 A; A=25-300.
DR   PDB; 3BP4; X-ray; 1.85 A; A=25-300.
DR   PDB; 3BP7; X-ray; 1.80 A; A=25-300.
DR   PDB; 3CZF; X-ray; 1.20 A; A=25-300.
DR   PDB; 3D18; X-ray; 1.74 A; A=25-300.
DR   PDB; 3DTX; X-ray; 2.10 A; A=25-300.
DR   PDB; 3HCV; X-ray; 1.95 A; A=25-300.
DR   PDB; 3LV3; X-ray; 1.94 A; A=25-300.
DR   PDB; 4G8G; X-ray; 2.40 A; A=25-300.
DR   PDB; 4G8I; X-ray; 1.60 A; A=25-300.
DR   PDB; 4G9D; X-ray; 1.60 A; A=25-300.
DR   PDB; 4G9F; X-ray; 1.90 A; A=25-300.
DR   PDBsum; 1HSA; -.
DR   PDBsum; 1JGD; -.
DR   PDBsum; 1JGE; -.
DR   PDBsum; 1K5N; -.
DR   PDBsum; 1OF2; -.
DR   PDBsum; 1OGT; -.
DR   PDBsum; 1ROG; -.
DR   PDBsum; 1ROH; -.
DR   PDBsum; 1ROI; -.
DR   PDBsum; 1ROJ; -.
DR   PDBsum; 1ROK; -.
DR   PDBsum; 1ROL; -.
DR   PDBsum; 1UXS; -.
DR   PDBsum; 1UXW; -.
DR   PDBsum; 1W0V; -.
DR   PDBsum; 1W0W; -.
DR   PDBsum; 2A83; -.
DR   PDBsum; 2BSR; -.
DR   PDBsum; 2BSS; -.
DR   PDBsum; 2BST; -.
DR   PDBsum; 3B3I; -.
DR   PDBsum; 3B6S; -.
DR   PDBsum; 3BP4; -.
DR   PDBsum; 3BP7; -.
DR   PDBsum; 3CZF; -.
DR   PDBsum; 3D18; -.
DR   PDBsum; 3DTX; -.
DR   PDBsum; 3HCV; -.
DR   PDBsum; 3LV3; -.
DR   PDBsum; 4G8G; -.
DR   PDBsum; 4G8I; -.
DR   PDBsum; 4G9D; -.
DR   PDBsum; 4G9F; -.
DR   ProteinModelPortal; P03989; -.
DR   SMR; P03989; 25-300.
DR   DIP; DIP-6188N; -.
DR   IntAct; P03989; 1.
DR   MINT; MINT-247525; -.
DR   SwissPalm; P03989; -.
DR   DMDM; 34305677; -.
DR   PRIDE; P03989; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; HLA-B; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MalaCards; HLA-B; -.
DR   MIM; 106300; phenotype.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P03989; -.
DR   HOVERGEN; HBG016709; -.
DR   PhylomeDB; P03989; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-B; human.
DR   EvolutionaryTrace; P03989; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-B; -.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IDA:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042605; F:peptide antigen binding; IDA:UniProtKB.
DR   GO; GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IDA:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006952; P:defense response; TAS:UniProtKB.
DR   GO; GO:0016045; P:detection of bacterium; IMP:UniProtKB.
DR   GO; GO:0006955; P:immune response; IMP:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Host-virus interaction; Immunity;
KW   Membrane; MHC I; Polymorphism; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24       {ECO:0000269|PubMed:2408663}.
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-27 alpha chain.
FT                                /FTId=PRO_0000018839.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                {ECO:0000244|PubMed:21269460}.
FT                                /FTId=VAR_056341.
FT   VARIANT      83     83       Y -> H (in allele B*27:03).
FT                                /FTId=VAR_016379.
FT   VARIANT     101    101       D -> N (in allele B*27:02).
FT                                /FTId=VAR_016380.
FT   VARIANT     101    101       D -> S (in allele B*27:04, allele B*27:06
FT                                and allele B*27:08; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_016381.
FT   VARIANT     104    105       TL -> IA (in allele B*27:02).
FT                                /FTId=VAR_016382.
FT   VARIANT     104    104       T -> N (in allele B*27:08).
FT                                /FTId=VAR_016383.
FT   VARIANT     106    107       LR -> RG (in allele B*27:08).
FT                                /FTId=VAR_016384.
FT   VARIANT     121    121       N -> S (in allele B*27:07).
FT                                /FTId=VAR_016385.
FT   VARIANT     137    138       YH -> HN (in allele B*27:07).
FT                                /FTId=VAR_016386.
FT   VARIANT     138    138       H -> D (in allele B*27:06).
FT                                /FTId=VAR_016387.
FT   VARIANT     140    140       D -> H (in allele B*27:09).
FT                                /FTId=VAR_016388.
FT   VARIANT     140    140       D -> Y (in allele B*27:06 and allele
FT                                B*27:07).
FT                                /FTId=VAR_016389.
FT   VARIANT     155    155       S -> R (in allele B*27:07).
FT                                /FTId=VAR_016390.
FT   VARIANT     176    176       V -> E (in allele B*27:04 and allele
FT                                B*27:06).
FT                                /FTId=VAR_016391.
FT   VARIANT     235    235       A -> G (in allele B*27:04 and allele
FT                                B*27:06).
FT                                /FTId=VAR_016392.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056342.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056343.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061402.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061403.
FT   CONFLICT    206    206       A -> V (in Ref. 2). {ECO:0000305}.
FT   CONFLICT    266    266       Q -> E (in Ref. 3; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       27     36       {ECO:0000244|PDB:1K5N}.
FT   STRAND       41     43       {ECO:0000244|PDB:1K5N}.
FT   STRAND       45     52       {ECO:0000244|PDB:1K5N}.
FT   STRAND       55     61       {ECO:0000244|PDB:1K5N}.
FT   STRAND       64     66       {ECO:0000244|PDB:1K5N}.
FT   HELIX        74     76       {ECO:0000244|PDB:1K5N}.
FT   HELIX        81    108       {ECO:0000244|PDB:1K5N}.
FT   STRAND      113    115       {ECO:0000244|PDB:1K5N}.
FT   STRAND      118    127       {ECO:0000244|PDB:1K5N}.
FT   STRAND      133    142       {ECO:0000244|PDB:1K5N}.
FT   STRAND      145    150       {ECO:0000244|PDB:1K5N}.
FT   STRAND      157    161       {ECO:0000244|PDB:1K5N}.
FT   HELIX       162    173       {ECO:0000244|PDB:1K5N}.
FT   HELIX       176    185       {ECO:0000244|PDB:1K5N}.
FT   HELIX       187    198       {ECO:0000244|PDB:1K5N}.
FT   TURN        199    204       {ECO:0000244|PDB:1K5N}.
FT   STRAND      210    219       {ECO:0000244|PDB:1K5N}.
FT   STRAND      222    235       {ECO:0000244|PDB:1K5N}.
FT   STRAND      238    243       {ECO:0000244|PDB:1K5N}.
FT   HELIX       249    251       {ECO:0000244|PDB:1K5N}.
FT   STRAND      252    254       {ECO:0000244|PDB:3HCV}.
FT   STRAND      261    263       {ECO:0000244|PDB:1K5N}.
FT   STRAND      265    274       {ECO:0000244|PDB:1K5N}.
FT   HELIX       278    280       {ECO:0000244|PDB:1K5N}.
FT   STRAND      281    286       {ECO:0000244|PDB:1K5N}.
FT   STRAND      290    292       {ECO:0000244|PDB:3CZF}.
FT   STRAND      294    296       {ECO:0000244|PDB:1K5N}.
SQ   SEQUENCE   362 AA;  40428 MW;  C8D2F154E3292031 CRC64;
     MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFHTSVSRPG RGEPRFITVG YVDDTLFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRETQI CKAKAQTDRE DLRTLLRYYN QSEAGSHTLQ
     NMYGCDVGPD GRLLRGYHQD AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RAYLEGECVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B38_HUMAN              Reviewed;         362 AA.
AC   Q95365; O19779; O77959; O78160; Q29935; Q29936; Q95IB8; Q95IH5;
AC   Q9BCM8; Q9MY92; Q9MYG1; Q9TPT2;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   17-FEB-2016, entry version 125.
DE   RecName: Full=HLA class I histocompatibility antigen, B-38 alpha chain;
DE   AltName: Full=Bw-4;
DE   AltName: Full=MHC class I antigen B*38;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE B*38:01).
RX   PubMed=7725307; DOI=10.1111/j.1399-0039.1995.tb02410.x;
RA   Adams E.J., Martinez-Naves E., Arnett K.L., Little A.-M., Tyan D.B.,
RA   Parham P.;
RT   "HLA-B16 antigens: sequence of the ST-16 antigen, further definition
RT   of two B38 subtypes and evidence for convergent evolution of B*3902.";
RL   Tissue Antigens 45:18-26(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*38:01).
RA   Morlighem G.;
RL   Submitted (NOV-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*38:02).
RA   Little A.-M., Domena J.D., Hildebrand W.H., Parham P.;
RL   Submitted (FEB-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*38:02).
RC   TISSUE=Blood;
RX   PubMed=12622774; DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:02).
RX   PubMed=9455497; DOI=10.1016/S0198-8859(97)00112-2;
RA   Steiner N.K., Ng J., Bush J., Hartzman R.J., Johnston-Dow L.,
RA   Hurley C.K.;
RT   "HLA-B alleles associated with the B15 serologically defined
RT   antigens.";
RL   Hum. Immunol. 56:84-93(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:02).
RA   Guttridge M.G., Hammond L., Darke C.;
RT   "Confirmatory sequence and serology of HLA-B*38021.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 26-206 (ALLELE B*38:03).
RX   PubMed=10323342; DOI=10.1034/j.1399-0039.1999.530408.x;
RA   Balas A., Santos S., Garcia-Sanchez F., Lillo R., Merino J.L.,
RA   Vicario J.L.;
RT   "Characterization of a new HLA-B*38 allele (B*3803) in a Spanish
RT   Caucasian individual which is closely related to the Oriental B*38021
RT   and B*39021 alleles.";
RL   Tissue Antigens 53:374-377(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES B*38:04 AND B*38:06).
RX   PubMed=11380951; DOI=10.1034/j.1399-0039.2001.057004373.x;
RA   Steiner N.K., Gans C.P., Kosman C., Baldassarre L.A., Edson S.,
RA   Jones P.F., Rizzuto G., Pimtanothai N., Koester R., Mitton W., Ng J.,
RA   Hartzman R.J., Hurley C.K.;
RT   "Novel HLA-B alleles associated with antigens in the 8C CREG.";
RL   Tissue Antigens 57:373-375(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-298 (ALLELE B*38:05).
RX   PubMed=11972879; DOI=10.1034/j.1399-0039.2002.590109.x;
RA   Garcia-Sanchez F., Fernandez-De-Velasco J., Lillo R.,
RA   Alvarez-Doval A., Rodriguez M.A., Aviles M.J., Balas A., Vicario J.L.;
RT   "Two new HLA class I alleles recognised by PCR sequence-specific
RT   primer and sequencing based typing: B*3805 and Cw*0408.";
RL   Tissue Antigens 59:47-48(2002).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:07).
RA   Cavett J.W., Hildebrand W.H., Bennett T.T., Sparkman J.N.;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*38:08).
RA   Chapman G., Dodd R., Greville W.D., Dunckley H.;
RT   "Novel HLA-B allele Identified by PCR SSO.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-298 (ALLELE B*38:01).
RX   PubMed=2777338; DOI=10.1007/BF02421207;
RA   Mueller C.A., Engler-Blum G., Gekeler V., Steiert I., Weiss E.,
RA   Schmidt H.;
RT   "Genetic and serological heterogeneity of the supertypic HLA-B locus
RT   specificities Bw4 and Bw6.";
RL   Immunogenetics 30:200-207(1989).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-65, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-87, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-69, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-38 are known: B*38:01,
CC       B*38:02, B*38:03, B*38:04, B*38:05, B*38:06, B*38:07 and B*38:08.
CC       The sequence shown is that of B*38:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36591; AAA73509.1; -; mRNA.
DR   EMBL; U40498; AAD00010.1; -; mRNA.
DR   EMBL; L22028; AAA59618.1; -; mRNA.
DR   EMBL; AJ297317; CAC29063.1; -; Genomic_DNA.
DR   EMBL; AH005604; AAB82305.1; -; Genomic_DNA.
DR   EMBL; AJ308991; CAC34965.1; -; Genomic_DNA.
DR   EMBL; AJ308992; CAC34965.1; JOINED; Genomic_DNA.
DR   EMBL; AF081275; AAC32198.1; -; mRNA.
DR   EMBL; AF081276; AAC32199.1; -; Genomic_DNA.
DR   EMBL; AH008211; AAD56222.1; -; Genomic_DNA.
DR   EMBL; AH009484; AAF78055.1; -; Genomic_DNA.
DR   EMBL; AH009277; AAF67340.1; -; Genomic_DNA.
DR   EMBL; AH010893; AAK69506.1; -; Genomic_DNA.
DR   EMBL; AH011066; AAL04500.1; -; Genomic_DNA.
DR   EMBL; M29864; AAA36222.1; -; Genomic_DNA.
DR   PIR; A59028; A59028.
DR   PIR; I54463; I54463.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; Q95365; -.
DR   SMR; Q95365; 25-298.
DR   SwissPalm; Q95365; -.
DR   DMDM; 34305608; -.
DR   PRIDE; Q95365; -.
DR   Ensembl; ENST00000425848; ENSP00000400842; ENSG00000223532.
DR   GeneCards; HLA-B; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MalaCards; HLA-B; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_Q95365; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2172127; DAP12 interactions.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-B; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-B; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-38 alpha chain.
FT                                /FTId=PRO_0000018842.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056347.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056348.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056349.
FT   VARIANT      35     35       S -> A (in allele B*38:05;
FT                                dbSNP:rs1131170).
FT                                /FTId=VAR_016411.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056350.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061407.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061408.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061409.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                {ECO:0000244|PubMed:21269460}.
FT                                /FTId=VAR_056351.
FT   VARIANT      69     69       E -> T (in allele B*38:06 and allele
FT                                B*38:07; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000244|PubMed:25944712}.
FT                                /FTId=VAR_016412.
FT   VARIANT      82     82       E -> G (in allele B*38:07).
FT                                /FTId=VAR_016413.
FT   VARIANT      87     87       N -> D (in dbSNP:rs1050570).
FT                                /FTId=VAR_056352.
FT   VARIANT      87     87       N -> E (in allele B*38:03 and allele
FT                                B*38:04; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000244|PubMed:24275569}.
FT                                /FTId=VAR_016414.
FT   VARIANT      87     87       N -> K (in dbSNP:rs1065386).
FT                                /FTId=VAR_059478.
FT   VARIANT      91     91       C -> F (in allele B*38:06 and allele
FT                                B*38:07).
FT                                /FTId=VAR_016415.
FT   VARIANT      91     91       C -> S (in allele B*38:03).
FT                                /FTId=VAR_016416.
FT   VARIANT      98     98       Y -> D (in allele B*38:03).
FT                                /FTId=VAR_016417.
FT   VARIANT     101    101       N -> S (in allele B*38:03).
FT                                /FTId=VAR_016418.
FT   VARIANT     104    104       I -> T (in allele B*38:02, allele
FT                                B*38:03, allele B*38:04 and allele
FT                                B*38:08).
FT                                /FTId=VAR_016419.
FT   VARIANT     187    187       T -> M (in allele B*38:08).
FT                                /FTId=VAR_016420.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056353.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056354.
FT   CONFLICT    130    131       DG -> ER (in Ref. 12; AAA36222).
FT                                {ECO:0000305}.
FT   CONFLICT    191    192       WL -> CV (in Ref. 12; AAA36222).
FT                                {ECO:0000305}.
SQ   SEQUENCE   362 AA;  40416 MW;  41F49A1A19DF21C7 CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRNTQI CKTNTQTYRE NLRIALRYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHNQF AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARVAEQL
     RTYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B46_HUMAN              Reviewed;         362 AA.
AC   P30484; Q9TPR2;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   09-DEC-2015, entry version 129.
DE   RecName: Full=HLA class I histocompatibility antigen, B-46 alpha chain;
DE   AltName: Full=Bw-46;
DE   AltName: Full=MHC class I antigen B*46;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*46:01).
RX   PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*46:01).
RC   TISSUE=Blood;
RX   PubMed=12622774; DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*46:02).
RX   PubMed=10885569; DOI=10.1034/j.1399-0039.2000.550511.x;
RA   Akesaka T., Kashiwase K., Shimamura M., Ishikawa Y., Tanaka H.,
RA   Fujii M., Akaza T., Honda K., Yuasa S., Takahashi T., Juji T.;
RT   "Identification of a novel HLA-B46 allele, B*4602, in Japanese.";
RL   Tissue Antigens 55:460-462(2000).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-46 are known: B*46:01 and
CC       B*46:02. The sequence shown is that of B*46:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24033; AAA59665.1; -; mRNA.
DR   EMBL; AJ310508; CAC34573.1; -; Genomic_DNA.
DR   EMBL; AB032091; BAA84111.1; -; Genomic_DNA.
DR   PIR; I61863; I61863.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 4LCY; X-ray; 1.60 A; A/F=25-298.
DR   PDBsum; 4LCY; -.
DR   ProteinModelPortal; P30484; -.
DR   SMR; P30484; 25-298.
DR   IntAct; P30484; 1.
DR   DMDM; 231407; -.
DR   PRIDE; P30484; -.
DR   Ensembl; ENST00000450871; ENSP00000388208; ENSG00000232126.
DR   GeneCards; HLA-B; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MalaCards; HLA-B; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30484; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-B; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-B; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-46 alpha chain.
FT                                /FTId=PRO_0000018849.
FT   TOPO_DOM     25    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      98     98       D -> G (in allele B*46:02).
FT                                /FTId=VAR_016473.
FT   STRAND       27     36       {ECO:0000244|PDB:4LCY}.
FT   TURN         39     41       {ECO:0000244|PDB:4LCY}.
FT   STRAND       45     52       {ECO:0000244|PDB:4LCY}.
FT   STRAND       55     61       {ECO:0000244|PDB:4LCY}.
FT   STRAND       68     71       {ECO:0000244|PDB:4LCY}.
FT   HELIX        74     76       {ECO:0000244|PDB:4LCY}.
FT   HELIX        81    108       {ECO:0000244|PDB:4LCY}.
FT   STRAND      113    115       {ECO:0000244|PDB:4LCY}.
FT   STRAND      118    127       {ECO:0000244|PDB:4LCY}.
FT   STRAND      133    142       {ECO:0000244|PDB:4LCY}.
FT   STRAND      145    150       {ECO:0000244|PDB:4LCY}.
FT   STRAND      157    161       {ECO:0000244|PDB:4LCY}.
FT   HELIX       164    173       {ECO:0000244|PDB:4LCY}.
FT   HELIX       176    185       {ECO:0000244|PDB:4LCY}.
FT   HELIX       187    198       {ECO:0000244|PDB:4LCY}.
FT   HELIX       200    203       {ECO:0000244|PDB:4LCY}.
FT   STRAND      210    235       {ECO:0000244|PDB:4LCY}.
FT   STRAND      238    243       {ECO:0000244|PDB:4LCY}.
FT   HELIX       249    251       {ECO:0000244|PDB:4LCY}.
FT   STRAND      261    263       {ECO:0000244|PDB:4LCY}.
FT   STRAND      265    274       {ECO:0000244|PDB:4LCY}.
FT   HELIX       278    280       {ECO:0000244|PDB:4LCY}.
FT   STRAND      281    286       {ECO:0000244|PDB:4LCY}.
FT   STRAND      294    296       {ECO:0000244|PDB:4LCY}.
SQ   SEQUENCE   362 AA;  40440 MW;  481B4C6876CB0E85 CRC64;
     MRVTAPRTVL LLLSGALALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRMA PRAPWIEQEG PEYWDRETQK YKRQAQTDRV SLRNLRGYYN QSEAGSHTLQ
     RMYGCDVGPD GRLLRGHDQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQW
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B48_HUMAN              Reviewed;         362 AA.
AC   P30486; Q29764;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   17-FEB-2016, entry version 127.
DE   RecName: Full=HLA class I histocompatibility antigen, B-48 alpha chain;
DE   AltName: Full=Bw-48;
DE   AltName: Full=MHC class I antigen B*48;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*48:01).
RX   PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J.,
RA   Williams R.C., Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*48:01).
RC   TISSUE=Blood;
RX   PubMed=12622774; DOI=10.1034/j.1399-0039.2003.610103.x;
RA   Cox S.T., McWhinnie A.J., Robinson J., Marsh S.G.E., Parham P.,
RA   Madrigal J.A., Little A.-M.;
RT   "Cloning and sequencing full-length HLA-B and -C genes.";
RL   Tissue Antigens 61:20-48(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-206 (ALLELE B*48:03).
RX   PubMed=10372543; DOI=10.1034/j.1399-0039.1999.530504.x;
RA   Marcos C.Y., Fernandez-Vina M.A., Lazaro A.M., Moraes M.E.,
RA   Moraes J.R., Stastny P.;
RT   "Novel HLA-A and HLA-B alleles in South American Indians.";
RL   Tissue Antigens 53:476-485(1999).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-65, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-48 are known: B*48:01 and
CC       B*48:03. The sequence shown is that of B*48:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84380; AAA59629.1; -; mRNA.
DR   EMBL; AJ309139; CAC38066.1; -; Genomic_DNA.
DR   EMBL; L76931; AAB59617.1; -; mRNA.
DR   PIR; I61903; I61903.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30486; -.
DR   SMR; P30486; 25-301.
DR   STRING; 9606.ENSP00000399168; -.
DR   SwissPalm; P30486; -.
DR   MaxQB; P30486; -.
DR   PaxDb; P30486; -.
DR   PRIDE; P30486; -.
DR   Ensembl; ENST00000412585; ENSP00000399168; ENSG00000234745.
DR   GeneCards; HLA-B; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   HPA; CAB015418; -.
DR   MalaCards; HLA-B; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30486; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   ChiTaRS; HLA-B; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; P30486; -.
DR   CleanEx; HS_HLA-B; -.
DR   ExpressionAtlas; P30486; baseline and differential.
DR   Genevisible; P30486; HS.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-48 alpha chain.
FT                                /FTId=PRO_0000018851.
FT   TOPO_DOM     25    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT       4      4       M -> T (in dbSNP:rs1050458).
FT                                /FTId=VAR_056391.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056392.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056393.
FT   VARIANT      35     35       S -> A (in dbSNP:rs1131170).
FT                                /FTId=VAR_056394.
FT   VARIANT      36     36       V -> M (in dbSNP:rs1050486).
FT                                /FTId=VAR_056395.
FT   VARIANT      48     48       S -> A (in dbSNP:rs713031).
FT                                /FTId=VAR_061426.
FT   VARIANT      48     48       S -> P (in dbSNP:rs713031).
FT                                /FTId=VAR_061427.
FT   VARIANT      48     48       S -> T (in dbSNP:rs713031).
FT                                /FTId=VAR_061428.
FT   VARIANT      65     65       A -> T (in dbSNP:rs1050529).
FT                                {ECO:0000244|PubMed:21269460}.
FT                                /FTId=VAR_056396.
FT   VARIANT     101    101       S -> N (in dbSNP:rs1050388).
FT                                /FTId=VAR_056397.
FT   VARIANT     121    121       S -> R (in allele B*48:03).
FT                                /FTId=VAR_016477.
FT   VARIANT     137    137       H -> Y (in dbSNP:rs1050379).
FT                                /FTId=VAR_056398.
FT   VARIANT     155    155       R -> S (in dbSNP:rs1050654).
FT                                /FTId=VAR_056399.
FT   VARIANT     187    187       E -> A (in dbSNP:rs2308466).
FT                                /FTId=VAR_059482.
FT   VARIANT     187    187       E -> G (in dbSNP:rs2308466).
FT                                /FTId=VAR_059483.
FT   VARIANT     187    187       E -> K (in dbSNP:rs2523600).
FT                                /FTId=VAR_059484.
FT   VARIANT     187    187       E -> Q (in dbSNP:rs2523600).
FT                                /FTId=VAR_059485.
FT   VARIANT     187    187       E -> V (in dbSNP:rs2308466).
FT                                /FTId=VAR_059486.
FT   VARIANT     195    195       Y -> H (in dbSNP:rs1050696).
FT                                /FTId=VAR_056400.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1131500).
FT                                /FTId=VAR_056401.
FT   VARIANT     329    329       A -> T (in dbSNP:rs1051488).
FT                                /FTId=VAR_056402.
FT   VARIANT     349    349       C -> S (in dbSNP:rs2308655).
FT                                /FTId=VAR_061429.
FT   VARIANT     349    349       C -> Y (in dbSNP:rs2308655).
FT                                /FTId=VAR_061430.
SQ   SEQUENCE   362 AA;  40362 MW;  8FADC7B64EBD5C8D CRC64;
     MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
     DSDAASPREE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE SLRNLRGYYN QSEAGSHTLQ
     SMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLRSWTAA DTAAQISQRK LEAARVAEQL
     RAYLEGECVE WLRRYLENGK DKLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWTA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
     TA
//
ID   1B49_HUMAN              Reviewed;         362 AA.
AC   P30487; O19625; Q9MY37; Q9MY93;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   17-FEB-2016, entry version 127.
DE   RecName: Full=HLA class I histocompatibility antigen, B-49 alpha chain;
DE   AltName: Full=HLA class I histocompatibility antigen, B-21 alpha chain;
DE   AltName: Full=MHC class I antigen B*49;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE B*49:01).
RX   PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [2]
RP   SEQUENCE REVISION TO 78.
RX   PubMed=1385528;
RA   Hildebrand W.H., Madrigal J.A., Belich M.P., Zemmour J., Ward F.E.,
RA   Williams R.C., Parham P.;
RT   "Serologic cross-reactivities poorly reflect allelic relationships in
RT   the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2
RT   helix.";
RL   J. Immunol. 149:3563-3568(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 1-322 (ALLELE B*49:01).
RA   Hurley C.K., Bei M., Rodriguez S., Johnson A.;
RL   Submitted (JUN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE B*49:02).
RA   Gans C.P., Hurley C.K.;
RT   "Novel HLA-B Allele.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*49:03).
RX   PubMed=11556975; DOI=10.1034/j.1399-0039.2001.057005478.x;
RA   Darke C., Street J., Guttridge M.G.;
RT   "Sequence, genetics and serology of a new HLA-B allele: B*4903.";
RL   Tissue Antigens 57:478-480(2001).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-49 are known: B*49:01,
CC       B*49:02 and B*49:03 (B*RA). The sequence shown is that of B*49:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24037; AAA02950.1; -; mRNA.
DR   EMBL; U11263; AAA19923.1; -; mRNA.
DR   EMBL; AH009483; AAF78054.1; -; Genomic_DNA.
DR   EMBL; AJ288980; CAB88084.1; -; Genomic_DNA.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   ProteinModelPortal; P30487; -.
DR   SMR; P30487; 25-300.
DR   SwissPalm; P30487; -.
DR   DMDM; 1345599; -.
DR   PRIDE; P30487; -.
DR   Ensembl; ENST00000435618; ENSP00000405178; ENSG00000224608.
DR   GeneCards; HLA-B; -.
DR   H-InvDB; HIX0166654; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MalaCards; HLA-B; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30487; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-B; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-B; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-49 alpha chain.
FT                                /FTId=PRO_0000018852.
FT   TOPO_DOM     25    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT       9      9       V -> L (in dbSNP:rs1050462).
FT                                /FTId=VAR_056403.
FT   VARIANT      17     17       L -> V (in dbSNP:rs1131165).
FT                                /FTId=VAR_056404.
FT   VARIANT      48     48       T -> A (in allele B*49:03).
FT                                /FTId=VAR_016512.
FT   VARIANT      56     56       L -> Q (in allele B*49:03).
FT                                /FTId=VAR_016513.
FT   VARIANT      65     65       T -> A (in allele B*49:03).
FT                                /FTId=VAR_016514.
FT   VARIANT      69     69       K -> T (in allele B*49:03).
FT                                /FTId=VAR_016515.
FT   VARIANT     104    104       I -> T (in allele B*49:02).
FT                                /FTId=VAR_016516.
SQ   SEQUENCE   362 AA;  40581 MW;  77B1C82AD3DAEB4A CRC64;
     MRVTAPRTVL LLLSAALALT ETWAGSHSMR YFHTAMSRPG RGEPRFITVG YVDDTLFVRF
     DSDATSPRKE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE NLRIALRYYN QSEAGSHTWQ
     RMYGCDLGPD GRLLRGYNQL AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//
ID   1B52_HUMAN              Reviewed;         362 AA.
AC   P30490; Q9MY75; Q9TPT4;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   09-DEC-2015, entry version 128.
DE   RecName: Full=HLA class I histocompatibility antigen, B-52 alpha chain;
DE   AltName: Full=Bw-52;
DE   AltName: Full=HLA class I histocompatibility antigen, B-5 alpha chain;
DE   AltName: Full=MHC class I antigen B*52;
DE   Flags: Precursor;
GN   Name=HLA-B; Synonyms=HLAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE B*52:01).
RX   PubMed=2909619;
RA   Hayashi H., Ennis P.D., Ariga H., Salter R.D., Parham P., Kano K.,
RA   Takiguchi M.;
RT   "HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the
RT   helical region of the alpha 1 domain.";
RL   J. Immunol. 142:306-311(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*52:02).
RA   Jones P.F., Hurley C.K.;
RT   "Novel HLA-B allele.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE B*52:03).
RA   Gans C.P., Hurley C.K.;
RT   "Novel HLA-B allele.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of B-52 are known: B*52:01,
CC       B*52:02 (B*52012V) and B*52:03. The sequence shown is that of
CC       B*52:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22799; AAA59645.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M22793; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22794; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22795; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22796; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22797; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; M22798; AAA59645.1; JOINED; Genomic_DNA.
DR   EMBL; AH008246; AAF00933.1; -; Genomic_DNA.
DR   EMBL; AH009592; AAF81610.1; -; Genomic_DNA.
DR   PIR; B30345; B30345.
DR   UniGene; Hs.654404; -.
DR   UniGene; Hs.77961; -.
DR   PDB; 3W39; X-ray; 3.10 A; A/D=25-300.
DR   PDBsum; 3W39; -.
DR   ProteinModelPortal; P30490; -.
DR   SMR; P30490; 25-300.
DR   PRIDE; P30490; -.
DR   Ensembl; ENST00000450871; ENSP00000388208; ENSG00000232126.
DR   GeneCards; HLA-B; -.
DR   HGNC; HGNC:4932; HLA-B.
DR   MalaCards; HLA-B; -.
DR   MIM; 142830; gene.
DR   neXtProt; NX_P30490; -.
DR   HOVERGEN; HBG016709; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-B; human.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-B; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    362       HLA class I histocompatibility antigen,
FT                                B-52 alpha chain.
FT                                /FTId=PRO_0000018855.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...). {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      69     70       TE -> MA (in allele B*52:02).
FT                                /FTId=VAR_016521.
FT   VARIANT     176    176       E -> V (in allele B*52:03).
FT                                /FTId=VAR_016522.
FT   VARIANT     195    195       H -> Y (in allele B*52:03).
FT                                /FTId=VAR_016523.
FT   STRAND       27     36       {ECO:0000244|PDB:3W39}.
FT   STRAND       39     41       {ECO:0000244|PDB:3W39}.
FT   STRAND       45     52       {ECO:0000244|PDB:3W39}.
FT   STRAND       55     61       {ECO:0000244|PDB:3W39}.
FT   STRAND       64     66       {ECO:0000244|PDB:3W39}.
FT   TURN         75     78       {ECO:0000244|PDB:3W39}.
FT   HELIX        81    109       {ECO:0000244|PDB:3W39}.
FT   STRAND      118    127       {ECO:0000244|PDB:3W39}.
FT   STRAND      133    142       {ECO:0000244|PDB:3W39}.
FT   STRAND      145    150       {ECO:0000244|PDB:3W39}.
FT   HELIX       162    172       {ECO:0000244|PDB:3W39}.
FT   TURN        173    175       {ECO:0000244|PDB:3W39}.
FT   HELIX       176    185       {ECO:0000244|PDB:3W39}.
FT   HELIX       187    198       {ECO:0000244|PDB:3W39}.
FT   HELIX       200    203       {ECO:0000244|PDB:3W39}.
FT   STRAND      212    217       {ECO:0000244|PDB:3W39}.
FT   STRAND      219    221       {ECO:0000244|PDB:3W39}.
FT   STRAND      223    235       {ECO:0000244|PDB:3W39}.
FT   STRAND      238    247       {ECO:0000244|PDB:3W39}.
FT   HELIX       249    251       {ECO:0000244|PDB:3W39}.
FT   STRAND      252    254       {ECO:0000244|PDB:3W39}.
FT   STRAND      261    263       {ECO:0000244|PDB:3W39}.
FT   STRAND      265    273       {ECO:0000244|PDB:3W39}.
FT   HELIX       277    280       {ECO:0000244|PDB:3W39}.
FT   STRAND      281    286       {ECO:0000244|PDB:3W39}.
SQ   SEQUENCE   362 AA;  40521 MW;  A32E36370FD84F91 CRC64;
     MRVTAPRTVL LLLWGAVALT ETWAGSHSMR YFYTAMSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASPRTE PRAPWIEQEG PEYWDRETQI SKTNTQTYRE NLRIALRYYN QSEAGSHTWQ
     TMYGCDVGPD GRLLRGHNQY AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL
     RAYLEGLCVE WLRRHLENGK ETLQRADPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
     SSQSTIPIVG IVAGLAVLAV VVIGAVVATV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL
     TA
//